hosted by
publicationslist.org
    

Masahiko Inamori


inamorim@med.yokohama-cu.ac.jp

Journal articles

2013
Hiroaki Yasuzaki, Shin-ichirou Yoshida, Tatsuo Hashimoto, Wataru Shibata, Masahiko Inamori, Yoshiyuki Toya, Kouichi Tamura, Shin Maeda, Satoshi Umemura (2013)  Involvement of the apelin receptor APJ in Fas-induced liver injury.   Liver international : official journal of the International Association for the Study of the Liver 33: 1. 118-126 Jan  
Abstract: Apelin-APJ signalling is known to play important roles in heart physiology and pathology; however, its functions in liver physiology and pathology remain unclear. On the other hand, Fas is an important molecule in hepatitis and other liver disease that belongs to the death receptor family. The aim of this study was to assess the relationship between apelin-APJ signaling and Fas-mediated liver injury in mice.
Notes:
Hidenori Ohkubo, Takaomi Kessoku, Akiko Fuyuki, Hiroshi Iida, Masahiko Inamori, Tetsuro Fujii, Harunobu Kawamura, Yasuo Hata, Noriaki Manabe, Toshimi Chiba, Thomas C Kwee, Ken Haruma, Nobuyuki Matsuhashi, Atsushi Nakajima, Taro Takahara (2013)  Assessment of Small Bowel Motility in Patients With Chronic Intestinal Pseudo-Obstruction Using Cine-MRI.   Am J Gastroenterol Mar  
Abstract: OBJECTIVES:Chronic intestinal pseudo-obstruction (CIPO) is a rare, serious motility disorder, with life-threatening complications over time. However, lack of an established, non-invasive diagnostic method has caused delays in the diagnosis of this intractable disease. Cine-magnetic resonance imaging (MRI) is an emerging technique, with a potential to evaluate the motility of the entire bowel. We compared small bowel motility in healthy volunteers, patients with irritable bowel syndrome (IBS), and those with CIPO, using cine-MRI, and evaluated the usefulness of cine-MRI as a novel diagnostic method for CIPO.METHODS:Twelve healthy volunteers, IBS patients, and CIPO patients prospectively underwent cine-MRI at 1.5 T. Luminal diameter, contraction ratio, and contraction cycle were measured and compared between the groups.RESULTS:Cine-MRI provided sufficient dynamic images to assess the motility of the entire small bowel. Luminal diameter (mean±s.d.) in CIPO patients was significantly higher than that in healthy volunteers and IBS patients (43.4±14.1, 11.1±1.5, and 10.9±1.9 mm, respectively), and contraction ratio was significantly lower in CIPO patients than that in healthy volunteers and IBS patients (17.1±11.0%, 73.0±9.3%, and 74.6±9.4%, respectively). No significant differences were observed in the contraction cycle.CONCLUSIONS:This study is the first to assess the clinical utility of cine-MRI in CIPO patients. Cine-MRI clearly detected contractility impairments in CIPO patients. Cine-MRI is noninvasive, radiation-free, and can directly evaluate the entire small bowel peristalsis, and can detect the affected loops at a glance; therefore, it might be extremely useful for the diagnosis and follow-up of CIPO patients in clinical practice.Am J Gastroenterol advance online publication, 19 March 2013; doi:10.1038/ajg.2013.57.
Notes:
Tomonori Ida, Taiki Morohashi, Hiroshi Ohara, Toru Goto, Masahiko Inamori, Atsushi Nakajima, Shin Maeda, Yoko Tsukumo, Atsuhiko Sakamoto, Yukio Ishikawa (2013)  Gastric Neuroendocrine Carcinoma with Non-islet Cell Tumor Hypoglycemia Associated with Enhanced Production of Insulin-like Growth Factor II.   Intern Med 52: 7. 757-760 04  
Abstract: A 75-year-old man was admitted to the hospital with a loss of consciousness. His blood glucose level was 24 mg/dL. Abdominal computed tomography revealed multiple metastatic lesions in the liver, while upper endoscopy disclosed advanced gastric cancer. The hypoglycemia was refractory despite the administration of glucose and steroid therapy. The patient died within one month of admission. An autopsy revealed neuroendocrine-type gastric cancer, which, on examination with immunohistochemistry, was found to be negative for insulin and insulin-like growth factor I and positive for insulin-like growth factor II (IGF-II). The patient was diagnosed as having gastric cancer with non-islet cell tumor hypoglycemia (NICTH) caused by IGF-II.
Notes:
Hiroshi Iida, Hidenori Ohkubo, Masahiko Inamori, Atsushi Nakajima, Hajime Sato (2013)  Epidemiology and clinical experience of chronic intestinal pseudo-obstruction in Japan: a nationwide epidemiologic survey.   Journal of epidemiology / Japan Epidemiological Association 23: 4. 288-294  
Abstract: Background: We estimated the prevalence and incidence of chronic intestinal pseudo-obstruction (CIPO) in Japan, investigated the patterns of hospital visits among those with CIPO, and examined present knowledge of CIPO among medical professionals.Methods: A self-administered questionnaire survey was distributed to targeted hospitals throughout Japan, which were selected using stratified random sampling. The questionnaire asked about the number of patients receiving treatment for CIPO, the frequency of their hospital visits, and overall clinical knowledge of CIPO among medical professionals.Results: CIPO prevalence was estimated to be 1.00 and 0.80 cases per 100 000 males and females, respectively. Incidence was 0.21 and 0.24 cases per 100 000 males and females, respectively. Prevalence and incidence did not significantly differ males and females. Mean age of patients was 63.1 years for males and 59.2 for females. Accurate diagnosis of CIPO sometimes required more than 3 months after initial presentation. Most medical professionals were unaware of or poorly understood CIPO.Conclusions: We estimated the prevalence and incidence of CIPO in Japan, using data from a nationwide survey. The findings suggest that knowledge of CIPO should be further disseminated so that the disease is not overlooked and is diagnosed without delay.
Notes:
Kenichiro Yabuki, Akira Kubota, Choichi Horiuchi, Takahide Taguchi, Goshi Nishimura, Masahiko Inamori (2013)  Limitations of PET and PET/CT in detecting upper gastrointestinal synchronous cancer in patients with head and neck carcinoma.   Eur Arch Otorhinolaryngol 270: 2. 727-733 Feb  
Abstract: The aim of this study was to verify the effectiveness of PET (positron emission tomography) or PET/CT (fusion images of PET with computed tomography) in detecting synchronous cancer in patients with head and neck carcinoma. We reviewed 682 patients with carcinoma of the head and neck between January 2001 and December 2010. In 98 patients, 111 synchronous cancers were diagnosed. Of these 98 patients, the index cancer was predominantly located in the hypopharynx (47 cases), followed by the larynx (23 cases), oropharynx (12 cases) and the oral cavity (6 cases). Esophageal cancer was diagnosed as the most synchronous cancer (57 lesions), followed by gastric cancer (20 lesions), lung cancer (9 lesions) and head and neck cancer (8 lesions). Among these 98 patients, PET or PET/CT was performed in 82 patients. Of these 82 patients, PET or PET/CT detected 34 out of 94 (36.2 %) synchronous cancers. No significant difference was observed between PET and PET/CT in terms of lesion detectability (p = 0.21). Regarding synchronous T1 and Tis upper gastrointestinal (UGI) cancer, PET or PET/CT detected 4 out of 43 (9.3 %) of the cancers. No statistical difference in detectability was observed in patients who underwent PET or PET/CT scanning before or after histological examination of synchronous UGI cancer. In conclusion, synchronous cancer was most frequently observed in the UGI, especially in the esophagus in patients with head and neck carcinoma. PET and PET/CT have limitations in the detection of these lesions.
Notes:
Takashi Nonaka, Takaomi Kessoku, Yuji Ogawa, Shogo Yanagisawa, Tadahiko Shiba, Takashi Sakaguchi, Kazuhiro Atsukawa, Hisao Takahashi, Yusuke Sekino, Hiroshi Iida, Hiroki Endo, Yasunari Sakamoto, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Shin Maeda, Atsushi Nakajima, Eiji Gotoh, Masahiko Inamori (2013)  Comparative Study of 2 Different Questionnaires in Japanese Patients: The Quality of Life and Utility Evaluation Survey Technology Questionnaire (QUEST) Versus the Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease Questionnaire (FSSG).   J Neurogastroenterol Motil 19: 1. 54-60 Jan  
Abstract: The aim of this study was to examine the convenience of the quality of life and utility evaluation survey technology (QUEST) questionnaire and the frequency scale for the symptoms of gastroesophageal reflux disease (FSSG) questionnaire as self-assessment diagnostic instrument.
Notes:
Takashi Nonaka, Yusuke Sekino, Hiroshi Iida, Eiji Yamada, Hidenori Ohkubo, Eiji Sakai, Takuma Higurashi, Kunihiro Hosono, Hiroki Endo, Tomoko Koide, Hirokazu Takahashi, Koji Fujita, Masato Yoneda, Ayumu Goto, Akihiko Kusakabe, Noritoshi Kobayashi, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Chihiro Nosaka, Masahiko Inamori (2013)  Early Effect of Single-dose Sitagliptin Administration on Gastric Emptying: Crossover Study Using the (13)C Breath Test.   Journal of neurogastroenterology and motility 19: 2. 227-232 Apr  
Abstract: BACKGROUNDAIMS: The gastrointestinal motility effects of endogenous incretin hormones enhanced by dipeptidyl peptidase-IV (DPP-IV) inhibitors have not yet been sufficiently investigated. The aim of this study was to determine whether single pre-prandial sitagliptin, the DPP-IV inhibitor, administration might have an effect on the rate of liquid gastric emptying using the (13)C-acetic acid breath test.
Notes:
2012
Eiji Sakai, Hiroki Endo, Leo Taniguchi, Yasuo Hata, Akiko Ezuka, Hajime Nagase, Eiji Yamada, Hidenori Ohkubo, Takuma Higurashi, Yusuke Sekino, Tomoko Koide, Hiroshi Iida, Kunihiro Hosono, Takashi Nonaka, Hirokazu Takahashi, Masahiko Inamori, Shin Maeda, Atsushi Nakajima (2012)  Factors predicting the presence of small bowel lesions in patients with obscure gastrointestinal bleeding.   Dig Endosc Dec  
Abstract: AIM: To identify the predictive factors for the presence of small bowel lesions in patients with obscure gastrointestinal bleeding (OGIB). METHODS: A total of 242 patients with OGIB (overt 149: occult 93) were retrospectively included in the present study. Capsule endoscopy (CE) was carried out to investigate the small bowel, and detected lesions were classified according to the P0-P2 system. Only P2 lesions were defined as significant lesions. Univariate and multivariate logistic regression analyses were carried out to define the predictive factors for the presence of small bowel lesions. RESULTS: In patients with overt OGIB, chronic kidney disease (CKD) ≥stage 4 (odds ratio [OR] 4.03; 95% confidence interval [CI] 1.45-11.1, P = 0.007) was identified as an independent predictor of the presence of vascular lesions, and a history of non-steroidalanti-inflammatory drug (NSAID) use as that of erosive/ulcerated lesions (OR 4.73; 95% CI 1.47-15.2, P = 0.009). However, in patients with occult OGIB, no significant predictors of the presence of vascular lesions were identified, whereas a history of low-dose aspirin (LDA) (OR 3.57; 95% CI 1.21-10.5, P = 0.02) and proton pump inhibitor (PPI) use (OR 3.18; 95% CI 1.02-9.92, P = 0.05) were identified as independent predictors of the presence of erosive/ulcerated lesions. CONCLUSIONS: Our results indicated that bleeding pattern and clinical characteristics could contribute to predicting the origin of OGIB.
Notes:
Akihiko Kusakabe, Ryuta Sugiura, Kaori Yamamoto, Nobuto Yokoi, Yoko Tsuzaki, Yuko Noda, Akiko Satou, Masato Okita, Hiromichi Mawatari, Masahiko Inamori (2012)  [Operational management in our hospice ward-from the viewpoint of supporting a patient's recuperation at home].   Gan To Kagaku Ryoho 39 Suppl 1: 39-41 Dec  
Abstract: Although many terminally ill cancer patients desire to receive medical treatment in palliative care units(PCUs or hospices), very few patients are actually able to receive such treatment. Our aim is to provide palliative care to as many people as possible. We have practiced palliative care in general wards and prioritized care according to the patient's prognosis on admission to our hospice. From April 2007 to March 2011, 87% patients were admitted to our hospital in accordance with their wishes. By adequate management of hospital wards, including PCUs, and unitizing the health resources of the area, terminally ill cancer patients may be able to spend more time at home prior to hospitalization.
Notes:
Hiroshi Iida, Hiroki Endo, Yusuke Sekino, Eiji Sakai, Takashi Uchiyama, Kunihiro Hosono, Takashi Nonaka, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori (2012)  A new non-invasive modality for recording sequential images and the pH of the small bowel.   Hepatogastroenterology 59: 114. 413-414 Mar/Apr  
Abstract: Before the introduction of capsule endoscopy and double-balloon endoscopy, there were no effective modalities for reliable evaluation of the small bowel. Recently, the SmartPill, a wireless pH/ pressure recording capsule, has been utilized to measure the whole gut transit time. However, there are few studies on the small bowel pH. The aim of this study was to investigate the relationship between small bowel disease and the small bowel pH, we designed a new modality, the 'pH capsule', to non-invasively record sequential images and the pH.
Notes:
Hiroshi Iida, Masahiko Inamori, Tetsuro Fujii, Yusuke Sekino, Hiroki Endo, Kunihiro Hosono, Takashi Nonaka, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Eiji Gotoh, Shin Maeda, Atsushi Nakajima (2012)  Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH.   BMC Gastroenterol 12: 03  
Abstract: The ideal medication for acid-related diseases should have a rapid onset of action to promote hemostasis and cause efficient resolution of symptoms. The aim of our study was to comparatively investigate the inhibitory effect on gastric acid secretion of a single oral administration of omeprazole plus mosapride with that of omeprazole alone.
Notes:
Yuki Homma, Hirotoshi Akiyama, Ryusei Matsuyama, Hirochika Makino, Yasunari Sakamoto, Masahiko Inamori, Atsushi Nakajima, Shin Maeda, Kuniya Tanaka, Chikara Kunisaki, Itaru Endo (2012)  Assessment of Gastric Emptying Function after Gastrectomy using a Real-Time 13C Breath Test.   Hepatogastroenterology 59: 119. Jan  
Abstract: Background/Aims: Effectiveness of gastric emptying after pylorus-preserving gastrectomy (PPG) remains unclear and a method for continuous assessment is needed. We assessed post-PPG gastric emptying with a continuous real-time 13C breath test (BreathID system, Oridion, Israel). Methodology: Gastric emptying function was assessed by 13C breath test in 12 post-PPG patients and 9 post-distal gastrectomy (DG) patients. Continuous 13C-acetic acid breath test was performed using the BreathID system. Endoscopic study was also completed. Results: Diarrhea was significantly less common in PPG than DG patients (p=0.021). No other questionnaire items and endoscopic findings showed a significant difference. In the 13C-acetic acid breath test, the gastric emptying coefficient (GEC) was significantly greater in PPG than DG patients (p=0.025). No other test parameters showed a significant difference. Conclusions: Emptying function in the remnant stomach was assessed successfully by the continuous 13C-acetic acid breath test. A greater GEC suggested better gastric emptying in PPG patients.
Notes:
Tomoyuki Iwasaki, Wataru Tomeno, Masato Yoneda, Masahiko Inamori, Jun Shirakawa, Kento Imajo, Keigo Kawashima, Yasuo Terauchi, Atsushi Nakajima (2012)  Non-alcoholic fatty liver disease adversely affects the glycemic control afforded by sitagliptin.   Hepatogastroenterology 59: 117. 1522-1525 Jul/Aug  
Abstract: Recently, high serum DPP-4 activity was found in patients with NAFLD. Therefore, the possibility of NAFLD adversely influencing the therapeutic effect afforded by DPP-4 inhibitors in type 2 diabetic patients was suggested.
Notes:
K Okada, J Fujisaki, T Yoshida, H Ishikawa, T Suganuma, A Kasuga, M Omae, M Kubota, A Ishiyama, T Hirasawa, A Chino, M Inamori, Y Yamamoto, N Yamamoto, T Tsuchida, Y Tamegai, A Nakajima, E Hoshino, M Igarashi (2012)  Long-term outcomes of endoscopic submucosal dissection for undifferentiated-type early gastric cancer.   Endoscopy 44: 2. 122-127 Feb  
Abstract: Endoscopic submucosal dissection (ESD) of undifferentiated-type early gastric cancer (UD-EGC) is technically feasible; however, the long-term clinical outcomes of the procedure have not yet been fully investigated. The aim of our study was to elucidate long-term outcomes of ESD for UD-EGC.
Notes:
Hiroshi Iida, Shingo Kato, Yusuke Sekino, Eiji Sakai, Takashi Uchiyama, Hiroki Endo, Kunihiro Hosono, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori (2012)  Early effects of oral administration of omeprazole and roxatidine on intragastric pH.   J Zhejiang Univ Sci B 13: 1. 29-34 Jan  
Abstract: The ideal medication for the treatment of acid-related diseases, e.g., peptic ulcers, stress-related gastric bleeding, functional dyspepsia, and gastroesophageal reflux disease, should have a rapid onset of action to promote hemostasis and relieve the symptoms. The aim of our study was to investigate the inhibitory effects on gastric acid secretion of a single oral administration of a proton pump inhibitor, omeprazole 20 mg, and an H(2)-receptor antagonist, roxatidine 75 mg.
Notes:
K Okada, T Tsuchida, A Ishiyama, T Taniguchi, S Suzuki, Y Horiuchi, Y Matsuo, N Yoshizawa, T Suganuma, M Omae, M Kubota, T Hirasawa, Y Yamamoto, M Inamori, N Yamamoto, A Nakajima, J Fujisaki, E Hoshino, K Kawabata, M Igarashi (2012)  Endoscopic mucosal resection and endoscopic submucosal dissection for en bloc resection of superficial pharyngeal carcinomas.   Endoscopy 44: 6. 556-564 Jun  
Abstract: Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are being used increasingly to treat superficial oropharyngeal and hypopharyngeal carcinomas. The aim of this study was to clarify whether ESD provided better results than EMR for en bloc and complete resection of superficial pharyngeal carcinomas.
Notes:
Hiroki Endo, Eiji Sakai, Takuma Higurashi, Eiji Yamada, Hidenori Ohkubo, Hiroshi Iida, Tomoko Koide, Masato Yoneda, Yasunobu Abe, Masahiko Inamori, Kunihiro Hosono, Hirokazu Takahashi, Kensuke Kubota, Atsushi Nakajima (2012)  Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopy.   Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 44: 10. 833-838 Oct  
Abstract: The differences in the small intestinal toxicity of low-dose aspirin based on the type of aspirin used remains unclear. The purpose of this study was to evaluate the differences in the small bowel mucosal injury between buffered and enteric-coated aspirin users by capsule endoscopy.
Notes:
Hidenori Ohkubo, Hiroshi Iida, Hirokazu Takahashi, Eiji Yamada, Eiji Sakai, Takuma Higurashi, Yusuke Sekino, Hiroki Endo, Yasunari Sakamoto, Masahiko Inamori, Hajime Sato, Kazuma Fujimoto, Atsushi Nakajima (2012)  An epidemiologic survey of chronic intestinal pseudo-obstruction and evaluation of the newly proposed diagnostic criteria.   Digestion 86: 1. 12-19 06  
Abstract: Chronic intestinal pseudo-obstruction (CIPO) is an intractable disease in which clinical symptoms of intestinal obstruction appear without mechanical cause. No clear diagnostic criteria have been established; therefore, we proposed diagnostic criteria to facilitate the diagnosis of this rare disease and aim to evaluate their usefulness and validity.
Notes:
Tomoyuki Akiyama, Yusuke Sekino, Hiroshi Iida, Shigeru Koyama, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori (2012)  Endoscopic diagnosis of Barrett's esophagus.   World J Gastroenterol 18: 26. 3477-3478 Jul  
Abstract: The Prague C and M Criteria have been developed for the objective endoscopic diagnosis of Barrett's esophagus (BE). BE arises between the squamocolumnar junction and the gastroesophageal junction at the proximal margin of the gastric folds. In this study, we reported that 43.0% of the subjects examined were diagnosed with BE based on the Prague C and M Criteria. Previous criticism by John Dent proposed that our data should be considered invalid because the prevalence of BE reported in our study was extraordinarily high and discordant with previous studies. Dent predicted that the position of the gastroesophageal junction in our study was judged to be lower than the actual position due to the effacement of the proximal ends of the gastric folds because of the routine use of a high degree of air distension during typical Japanese endoscopic examinations. The endoscopic evaluation of the superior gastric folds is certainly influenced by the degree of air distension of the esophagus. However, in our study, the proximal limit of the gastric mucosal folds was prospectively imaged while the oesophagus was minimally insufflated. Then, under a high level of air distension, the distal ends of the palisade-shaped longitudinal vessels were imaged because they are more easily observed when distended. In the majority of patients, the distal ends of the palisade-shaped longitudinal vessels correspond to the proximal limit of the gastric mucosal folds. Our endoscopic evaluation was appropriately performed according to the Prague C and M Criteria. We suspect that the high prevalence of BE in our study may be due to the inclusion of ultrashort-segment BE, which defines BE with an affected mucosal length under 5 mm, in our positive results.
Notes:
Y Sekino, E Yamada, E Sakai, H Ohkubo, T Higurashi, H Iida, H Endo, H Takahashi, T Koide, Y Sakamoto, T Nonaka, E Gotoh, S Maeda, A Nakajima, M Inamori (2012)  Influence of sumatriptan on gastric accommodation and on antral contraction in healthy subjects assessed by ultrasonography.   Neurogastroenterol Motil 24: 12. 1083-e564 Dec  
Abstract: Oral sumatriptan administration has been reported to delay gastric emptying after liquid meals. The aim of this study was to determine whether delayed gastric emptying is caused by enhanced gastric accommodation, impaired antral contractions, or both using ultrasonography.
Notes:
Kunihiro Hosono, Eiji Yamada, Hiroki Endo, Hirokazu Takahashi, Masahiko Inamori, Yoshitaka Hippo, Hitoshi Nakagama, Atsushi Nakajima (2012)  Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas.   World J Gastroenterol 18: 38. 5360-5368 Oct  
Abstract: To determine the expression statuses of tumor necrosis factor (TNF)-α, its receptors (TNF-R) and downstream effector molecules in human colorectal adenomas.
Notes:
Takashi Uchiyama, Hirokazu Takahashi, Hiroki Endo, Shingo Kato, Eiji Sakai, Kunihiro Hosono, Masato Yoneda, Masahiko Inamori, Yoshitaka Hippo, Hitoshi Nakagama, Atsushi Nakajima (2012)  Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence.   Dig Endosc 24: 5. 353-357 Sep  
Abstract: Endoscopic screening and removal of colorectal adenomas can reduce the incidence of colorectal cancer. However, given the possibility of adenoma recurrence, surveillance colonoscopy is currently recommended after the initial screening and removal of colorectal adenomas. Aberrant crypt foci (ACF) have been shown to serve as a reliable surrogate marker of colorectal carcinogenesis. In this study, the relationship between the number of ACF at the initial endoscopic polypectomy and the likelihood of colorectal adenoma recurrence after polypectomy were investigated.
Notes:
Kaori Suzuki, Shiori Uchiyama, Kento Imajyo, Wataru Tomeno, Eiji Sakai, Eiji Yamada, Emiko Tanida, Tomoyuki Akiyama, Seitaro Watanabe, Hiroki Endo, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Yasunobu Abe, Minoru Kawaguchi, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori (2012)  Risk factors for colonic diverticular hemorrhage: Japanese multicenter study.   Digestion 85: 4. 261-265 03  
Abstract: Diverticular hemorrhage is the common cause of lower gastrointestinal bleeding, and its incidence has been increasing in Japan. However, the exact cause of diverticular hemorrhage is not well understood. We investigated the risk factors for diverticular hemorrhage.
Notes:
Y Sekino, H Endo, E Yamada, E Sakai, H Ohkubo, T Higurashi, H Iida, K Hosono, H Takahashi, T Koide, T Nonaka, Y Abe, E Gotoh, S Maeda, A Nakajima, M Inamori (2012)  Clinical associations and risk factors for bleeding from colonic angiectasia: a case-controlled study.   Colorectal Dis 14: 10. e740-e746 Oct  
Abstract: A case-controlled study was performed to investigate the association of colonic angiectasia with other conditions and to identify risk factors for bleeding.
Notes:
2011
Takashi Nonaka, Takaomi Kessoku, Yuji Ogawa, Shogo Yanagisawa, Tadahiko Shiba, Takashi Sahaguchi, Kazuhiro Atsukawa, Hisao Takahashi, Yusuke Sekino, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Yasunari Sakamoto, Tomoko Koide, Hirokazu Takahashi, Chikako Tokoro, Yasunobu Abe, Shin Maeda, Atsushi Nakajima, Masahiko Inamori (2011)  Does postprandial itopride intake affect the rate of gastric emptying? A crossover study using the continuous real time 13C breath test (BreathID system).   Hepatogastroenterology 58: 105. 224-228 Jan/Feb  
Abstract: The aim of this study was to determine whether oral Itopride hydrochloride (itopride) intake might have any effect on the rate of gastric emptying, using a novel non-invasive technique for measuring the rate of gastric emptying, namely, the continuous real time 13C breath test (BreathID system: Exalenz Bioscience Ltd., Israel).
Notes:
Nobutaka Fujisawa, Masahiko Inamori, Hiroki Endo, Takashi Uchiyama, Kunihiro Hosono, Tomoyuki Akiyama, Ayako Tomimoto, Sigeru Koyama, Aya Sawabe, Emiko Tanida, Shogo Yanagisawa, Yasuo Hata, Kazuhisa Okada, Kazuhiro Atsukawa, Seitaro Watanabe, Harunobu Kawamura, Takuma Higurashi, Hajime Nagase, Keiko Akimoto, Nobuyuki Matsuhashi, Atsushi Nakajima (2011)  Incidence of and risk factors for upper gastrointestinal complications in patients taking low-dose aspirin in Japan.   Hepatogastroenterology 58: 105. 229-234 Jan/Feb  
Abstract: Low-dose aspirin is widely used for the prevention of cardiovascular and cerebrovascular diseases. However, administration of low-dose aspirin is associated with an increased risk of upper gastrointestinal complications, such as upper gastrointestinal erosions, ulcers and bleeding. The aim of this study was to clarify the prevalence and various clinical factors of upper gastrointestinal complications associated with low-dose aspirin treatment.
Notes:
Kunihiro Hosono, Hiroki Endo, Eiji Sakai, Yusuke Sekino, Takashi Uchiyama, Seitaro Watanabe, Hiroshi Iida, Yasunari Sakamoto, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Chikako Tokoro, Yasunobu Abe, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Atsushi Nakajima (2011)  Optimal approach for small bowel capsule endoscopy using polyethylene glycol and metoclopramide with the assistance of a real-time viewer.   Digestion 84: 2. 119-125 04  
Abstract: Capsule endoscopy is limited by the poor image quality of the distal bowel and incomplete small bowel transit. The aim of this study was to establish an optimal medication protocol for capsule endoscopy performed using a real-time viewer.
Notes:
Hitoshi Kuriyama, Kenichi Kawana, Reo Taniguchi, Fumitake Jono, Eiji Sakai, Hidenori Okubo, Hirobumi Suzuki, Satoshi Kobayashi, Yoriko Murata, Masahiko Inamori, Yasuo Hata, Atsushi Nakajima (2011)  Single-agent gemcitabine in elderly patients with unresectable biliary tract cancer.   Hepatogastroenterology 58: 105. 26-30 Jan/Feb  
Abstract: This study examines the effect of systemic chemotherapy with gemcitabine (GEM) on survival in elderly patients (aged > or =70 years) with unresectable biliary tract cancer and compares it with best supportive care (BSC).
Notes:
Takashi Kaneko, Reikei Matsuda, Masataka Taguri, Masahiko Inamori, Asami Ogura, Eiji Miyajima, Katsuaki Tanaka, Shin Maeda, Hideaki Kimura, Reiko Kunisaki (2011)  Clostridium difficile infection in patients with ulcerative colitis: investigations of risk factors and efficacy of antibiotics for steroid refractory patients.   Clin Res Hepatol Gastroenterol 35: 4. 315-320 Apr  
Abstract: The incidence of Clostridium difficile infection (CDI) has increased throughout the world and patients with ulcerative colitis (UC) are at a high risk for CDI. Potentially, CDI can exacerbate UC. Therefore, knowledge on the prevalence of CDI should contribute to better management of UC patients.
Notes:
Hiroshi Iida, Masahiko Inamori, Tahashi Uchiyama, Hiroki Endo, Kunihiro Hosono, Tomoyuki Akiyama, Yasunari Sakamoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Tomoko Koide, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima (2011)  Early effects of oral administration of lafutidine with peppermint oil, compared with lafutidine alone, on intragastric pH values.   Hepatogastroenterology 58: 105. 235-238 Jan/Feb  
Abstract: Ideally, medications for the treatment of acid-related diseases should have a rapid onset of action to promote hemostasis and the resolution of symptoms. The aim of our study was to investigate the inhibitory effects on gastric acid secretion of a single oral administration of lafutidine alone or combined with peppermint oil.
Notes:
Kazuhisa Okada, Junko Fujisaki, Akiyoshi Kasuga, Masami Omae, Toshiaki Hirasawa, Akiyoshi Ishiyama, Masahiko Inamori, Akiko Chino, Yorimasa Yamamoto, Tomohiro Tsuchida, Atsushi Nakajima, Etsuo Hoshino, Masahiro Igarashi (2011)  Diagnosis of undifferentiated type early gastric cancers by magnification endoscopy with narrow-band imaging.   J Gastroenterol Hepatol 26: 8. 1262-1269 Aug  
Abstract:   The diagnostic use of magnification endoscopy with narrow-band imaging (ME-NBI) to assess histopathologically undifferentiated-type early gastric cancers (UD-type EGCs) is not well elucidated. The purpose of this study was to examine the comparative relationship between ME-NBI images and histopathological findings in UD-type EGCs.
Notes:
Hiroki Endo, Kunihiro Hosono, Takuma Higurashi, Eiji Sakai, Hiroshi Iida, Yasunari Sakamoto, Koji Fujita, Hirokazu Takahashi, Tomoko Koide, Masato Yoneda, Chikako Tokoro, Masahiko Inamori, Yasunobu Abe, Nobuyuki Matsuhashi, Atsushi Nakajima (2011)  Quantitative analysis of low-dose aspirin-associated small bowel injury using a capsule endoscopy scoring index.   Dig Endosc 23: 1. 56-61 Jan  
Abstract: The major limitation of capsule endoscopy (CE) has been the lack of a standardized and validated severity scale for mucosal injury. The aim of the present study was to verify the usefulness of quantifying small bowel mucosal changes associated with giving low-dose aspirin (LDA) using a CE scoring index.
Notes:
Yusuke Sekino, Hiroshi Iida, Hiroki Endo, Yasunari Sakamoto, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Chikako Tokoro, Yasunobu Abe, Atsushi Nakajima, Shin Maeda, Masahiro Takihata, Yasuo Terauchi, Masahiko Inamori (2011)  Effectiveness of repeated intragastric balloon therapy in a morbidly obese Japanese patient.   Intern Med 50: 2. 109-112 01  
Abstract: A 19-year-old Japanese male with a BMI of 55.4 kg/m(2) who also had liver dysfunction, dyslipidemia and hyperuricemia underwent repeated intragastric balloon therapy. The percent excess weight loss was 22.5% at the first balloon removal and 28.6% at the second balloon removal. The hepatic dysfunction resolved after the second balloon therapy, however, the dyslipidemia and hyperuricemia did not improve. The Japanese population is regarded as a high-risk race for obesity-related diseases at lower BMI values, and morbidly obese Japanese patients may need more serious weight reduction protocols to improve the comorbidities than similarly obese Americans or Europeans.
Notes:
Masato Yoneda, Shingo Kato, Hironori Mawatari, Hiroyuki Kirikoshi, Kento Imajo, Koji Fujita, Hiroki Endo, Hirokazu Takahashi, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Iwai Tohnai, Kei Watanuki, Koichiro Wada, Shin Maeda, Atsushi Nakajima (2011)  Liver abscess caused by periodontal bacterial infection with Fusobacterium necrophorum.   Hepatol Res 41: 2. 194-196 Feb  
Abstract: Liver abscess is recognized as a life-threatening disease. However, even in recent years, approximately 50% of liver abscess cases are considered to be cryptogenic. Here, we report a case of liver abscess associated with periodontal bacterial infection by Fusobacterium necrophorum, which is commonly found in the oropharyngeal flora. A 36-year-old man presented with fever and contrast-enhanced abdominal computed tomography revealed multiple liver abscesses. F.necrophorum was isolated from oral smears, liver aspirates and blood samples. Liver abscesses caused by periodontal bacterial infection are rare, however, the incidence is expected to increase in the future, as periodontitis is extremely common and is on the rise as one of the most common chronic infections in the world. A systemic survey including periodontitis may be required for the exact diagnosis of the source of infection.
Notes:
Chikako Tokoro, Masahiko Inamori, Tomoko Koide, Yusuke Sekino, Hiroshi Iida, Yasunari Sakamoto, Hiroki Endo, Kunihiro Hosono, Hirokazu Takahashi, Masato Yoneda, Hiroaki Yasuzaki, Masami Ogawa, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Ichiro Kawana, Atsushi Nakajima, Shin Maeda, Reikei Matsuda, Daisuke Takahashi (2011)  Influence of pretreatment with H2 receptor antagonists on the cure rates of Helicobacter pylori eradication.   Med Sci Monit 17: 5. CR235-CR240 May  
Abstract: Pretreatment with a proton pump inhibitor (PPI) reportedly decreases the efficacy of Helicobacter pylori (H. pylori) eradication, however, the effect of pretreatment with an H2 receptor antagonist (H2RA) on H. pylori eradication has not yet been studied. We compared the efficacy of eradication regimen (lansoprazole/amoxicillin/clarithromycin) in patients with H. pylori infection with or without H2RA pretreatment.
Notes:
Tomoyuki Akiyama, Masato Yoneda, Shin Maeda, Atsushi Nakajima, Shigeru Koyama, Masahiko Inamori (2011)  Visceral obesity and the risk of Barrett's esophagus.   Digestion 83: 3. 142-145 01  
Abstract: It still remains controversial whether simple obesity, as measured by the body mass index (BMI), is an independent risk factor for Barrett's esophagus (BE). Recent studies have shown abdominal obesity, as defined by the waist circumference (WC) and the waist-to-hip ratio (WHR), to be a risk factor for BE, independent of the BMI, with the association between BMI and BE being no longer observed after adjustment for the WC and WHR. Moreover, visceral obesity, as directly measured by the surface area of the visceral adipose tissue (VAT) on abdominal CT images, has also been reported to have an association with the risk of BE. In addition to the mechanical effects of abdominal obesity, that is, increase of the intra- abdominal pressure by the large amount of adipose tissue, circulating factors secreted from the VAT, such as tumor necrosis factor-α, interleukin-6, leptin, and adiponectin, have also been proposed to be pathogenetically linked to BE and esophageal adenocarcinoma. Obesity is associated with the risk of BE, and this risk appeared to be mediated for the most part by abdominal obesity, especially visceral obesity. This raises several questions regarding the pathogenesis of obesity-related BE. Larger studies with prospective enrollment of patients are required for further examination of this issue.
Notes:
Kensuke Kubota, Shingo Kato, Takashi Uchiyama, Seitaro Watanabe, Yuich Nozaki, Koji Fujita, Masato Yoneda, Masahiko Inamori, Takeshi Shimamura, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Satoru Saito, Atsushi Nakajima (2011)  Discrimination between sclerosing cholangitis-associated autoimmune pancreatitis and primary sclerosing cholangitis, cancer using intraductal ultrasonography.   Dig Endosc 23: 1. 10-16 Jan  
Abstract: Differentiation of sclerosing cholangitis-associated autoimmune pancreatitis (SC-AIP), primary sclerosing cholangitis (PSC) and cancer of the hilar part of the bile duct (CHB) has been challenging. The aim of the present study was to evaluate characteristic intraductal ultrasonography (IDUS) features that could be used to discriminate SC-AIP from PSC and CHB.
Notes:
Kensuke Kubota, Shingo Kato, Seitaro Watanabe, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Masahiko Inamori, Takeshi Shimamura, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Satoru Saito, Kantaro Hisatomi, Nobuyuki Matsuhashi, Atsushi Nakajima (2011)  Usefulness of endoscopic biopsy using FOXP3+ Treg up-regulation in the duodenal papilla in the differential diagnosis between autoimmune pancreatitis and pancreatic cancer.   J Hepatobiliary Pancreat Sci 18: 3. 414-421 May  
Abstract: Expression of the forkhead/winged helix family of transcription factor P3+ regulatory T cells (FOXP3(+) Treg), a master gene of regulatory T cells (Treg) is observed in patients with autoimmune pancreatitis (AIP). We investigated the usefulness of detection of FOXP3(+) Treg in the main duodenal papilla for differential diagnosis between AIP and pancreatic cancer (Pca).
Notes:
Kazuhisa Okada, Junko Fujisaki, Akiyoshi Kasuga, Masami Omae, Manabu Kubota, Toshiaki Hirasawa, Akiyoshi Ishiyama, Masahiko Inamori, Akiko Chino, Yorimasa Yamamoto, Tomohiro Tsuchida, Atsushi Nakajima, Etsuo Hoshino, Masahiro Igarashi (2011)  Sporadic nonampullary duodenal adenoma in the natural history of duodenal cancer: a study of follow-up surveillance.   Am J Gastroenterol 106: 2. 357-364 Feb  
Abstract: Although sporadic nonampullary duodenal adenoma (SNDA) is regarded as a precancerous lesion, its natural course is uncertain. The aim of this study was to evaluate the risk of development of adenocarcinoma in SNDA lesions initially diagnosed as showing low-grade dysplasia (LGD; category 3) or high-grade dysplasia (HGD; category 4.1).
Notes:
Takashi Uchiyama, Hirokazu Takahashi, Michiko Sugiyama, Eiji Sakai, Hiroki Endo, Kunihiro Hosono, Kyoko Yoneda, Masato Yoneda, Masahiko Inamori, Yoji Nagashima, Yoshiaki Inayama, Koichiro Wada, Atsushi Nakajima (2011)  Leptin receptor is involved in STAT3 activation in human colorectal adenoma.   Cancer Sci 102: 2. 367-372 Feb  
Abstract: The possible role of leptin in colorectal tumors has been investigated in previous studies; however, to date, the conclusions remain under debate. Therefore, we investigated the serum leptin levels in colorectal adenoma patients. In addition, expression of the leptin receptor, and the leptin receptor-mediated signaling pathways were investigated in biopsy specimens collected from human patients with colorectal adenoma. No significant difference in the mean serum leptin level was observed between the colorectal adenoma patients and the control subjects; however, increased expression and activation of the leptin receptor, as indicated by findings such as the phosphorylation of Tyr 1141, was observed in the colorectal adenoma tissues. In addition, activation of the JAK/STAT signaling pathway mediated by the leptin receptor and increased transcriptional regulation of downstream target molecules were observed in colorectal adenomas compared with the non-adenoma tissues. These results indicate STAT3-mediated leptin receptor signaling pathways may be activated in human colorectal adenomas.
Notes:
Koji Fujita, Kento Imajo, Yoshiyasu Shinohara, Yuichi Nozaki, Koichiro Wada, Masato Yoneda, Hiroki Endo, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Takeshi Shimamura, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima (2011)  Novel findings for the development of drug therapy for various liver diseases: Liver microsomal triglyceride transfer protein activator may be a possible therapeutic agent in non-alcoholic steatohepatitis.   J Pharmacol Sci 115: 3. 270-273 02  
Abstract: The factors involved in the progression of non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH) are not fully understood and thus it is urgently needed to elucidate these factors. Steatosis is not causal in the development of NASH, but rather it sensitizes the liver to the damaging effects of second hits such that stressors innocuous to a healthy liver lead to the development of NASH in the steatotic liver. In the previous study, most of the hepatic lipid metabolite profiles were similar in the NAFL and NASH groups. However, very-low-density lipoprotein (VLDL) synthesis, especially hepatic microsomal triglyceride transfer protein (MTP) mRNA expression, was impaired in the NASH group. Moreover, NASH showed significantly higher incidence of minor alley appearance compared with NAFL, indicating the possibility of association between NASH pathogenesis and decreased congenital MTP activity. MTP is one of the enzymes that transfer triglycerides to nascent apolipoprotein B, producing VLDL and removing lipid from the hepatocyte. A growing body of literature suggests that the measurement of hepatic MTP expression may be helpful for diagnosis; and moreover, hepatic MTP activator may be a possible therapeutic agent for the treatment of NASH.
Notes:
Koji Fujita, Koichiro Wada, Yuichi Nozaki, Masato Yoneda, Hiroki Endo, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Satoru Saito, Atsushi Nakajima (2011)  Serum nitric oxide metabolite as a biomarker of visceral fat accumulation: clinical significance of measurement for nitrate/nitrite.   Med Sci Monit 17: 3. CR123-CR131 Feb  
Abstract: A visceral fat area of more than 100 cm2 as measured by computed tomography (CT) at the umbilical level has been included as a criterion for obesity in all the proposed criteria for metabolic syndrome. However, CT cannot be used frequently because of radiation exposure. We evaluated the usefulness of measurement of the serum levels of nitric oxide (NO), instead of CT and the waist circumference, as a marker of abdominal visceral fat accumulation.
Notes:
Tomoyuki Iwasaki, Masato Yoneda, Masahiko Inamori, Jun Shirakawa, Takuma Higurashi, Shin Maeda, Yasuo Terauchi, Atsushi Nakajima (2011)  Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitus.   Hepatogastroenterology 58: 112. 2103-2105 Nov/Dec  
Abstract: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver injury, and is considered as the hepatic manifestation of metabolic syndrome. However, no effective drug therapy for NAFLD has been established yet. In the present study, we evaluated the efficacy of 4 months of treatment with sitagliptin in NAFLD patients with type 2 diabetes mellitus (DM).
Notes:
Hitoshi Kuriyama, Kenichi Kawana, Reo Taniguchi, Fumitake Jono, Eiji Sakai, Hidenori Ohubo, Hirobumi Suzuki, Satoshi Kobayashi, Yoriko Murata, Masahiho Inamori, Yasuo Hata, Atsushi Nahajima (2011)  Single-agent gemcitabine in elderly patients with unresectable biliary tract cancer.   Hepatogastroenterology 58: 106. 270-274 Mar/Apr  
Abstract: This study examined the effect of systemic chemotherapy with gemcitabine (GEM) on survival in elderly patients (aged > or = 70 years) with unresectable biliary tract cancer as compared with best supportive care (BSC).
Notes:
Shingo Kato, Kensuke Kubota, Takeshi Shimamura, Yoshiyasu Shinohara, Noritoshi Kobayashi, Seitaro Watanabe, Masato Yoneda, Masahiko Inamori, Fumio Nakamura, Hitoshi Ishiguro, Noboru Nakaigawa, Yoji Nagashima, Masataka Taguri, Yoshinobu Kubota, Yoshio Goshima, Satoshi Morita, Itaru Endo, Shin Maeda, Atsushi Nakajima, Hitoshi Nakagama (2011)  Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.   Cancer Sci 102: 11. 2029-2037 Nov  
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor, for which the development of new biomarkers and therapeutic targets has become critical. The main cause of poor prognosis in PDAC patients is the high invasive and metastatic potential of the cancer. In the present study, we report a new signaling pathway that was found to mediate the enhanced tumor cell motility in pancreatic cancer. Semaphorin 4D (Sema4D) is a ligand known to be expressed on different cell types, and has been reported to be involved in the regulation of immune functions, epithelial morphogenesis, and tumor growth and metastasis. In this study, we revealed for the first time that the cancer tissue cells expressing Sema4D in PDAC are tumor-infiltrating lymphocytes. The overexpression of Sema4D and of its receptor, plexinB1, was found to be significantly correlated with clinical factors, such as lymph node metastasis, distant metastasis, and poor prognosis in patients with PDAC. Through in vitro analysis, we demonstrated that Sema4D can potentiate the invasiveness of pancreatic cancer cells and we identified the downstream molecules. The binding of Sema4D to plexinB1 induced small GTPase Ras homolog gene family, member A activation and resulted in the phosphorylation of MAPK and Akt. In addition, in terms of potential therapeutic application, we clearly demonstrated that the enhanced-cell invasiveness induced by Sema4D could be inhibited by knockdown of plexinB1, suggesting that blockade of plexinB1 might diminish the invasive potential of pancreatic cancer cells. Our findings provide new insight into possible prognostic biomarkers and therapeutic targets in PDAC patients.
Notes:
Takashi Nonaka, Masahiko Inamori, Tadaomi Kessoku, Yuji Ogawa, Shogo Yanagisawa, Tadahiko Shiba, Takashi Sakaguchi, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Kazuhiro Atsukawa, Hisao Takahasi, Yoshikiyo Akasaka (2011)  A case of rectal cancer arising from long-standing prolapsed mucosa of the rectum.   Intern Med 50: 21. 2569-2573 11  
Abstract: Mucosal prolapse syndrome (MPS) has been recognized as a chronic benign inflammatory disorder, characterized mainly by rectal mucosal prolapse. Disorders representing this condition include solitary rectal ulcer syndrome (SRUS), rectal prolapse, proctitis cystica profunda, and inflammatory cap polyps. The gross appearance of rectal MPS can be occasionally misinterpreted as rectal cancer. In contrast, there have been a few reports of colorectal cancer originating from prolapsed mucosa. Herein, we report a case of MPS associated with two independent rectal cancers extending into the submucosal layer. We speculate that long-standing MPS may increase the risk of malignant transformation.
Notes:
Takuma Higurashi, Hiroki Endo, Masato Yoneda, Kunihiro Hosono, Eiji Sakai, Hirokazu Takahashi, Masahiko Inamori, Shiori Uchiyama, Takuto Kojima, Kenichi Kawana, Yutaka Natsumeda, Hajime Nagase, Atsushi Nakajima (2011)  Capsule-endoscopic findings of ulcerative colitis patients.   Digestion 84: 4. 306-314 10  
Abstract: Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by diffuse mucosal inflammation, traditionally regarded as being limited to the colorectum. Although several gastroduodenal lesions have also been reported recently in cases of UC, in general, small-bowel lesions in UC are believed to be extremely rare. The aim of this study was to examine the small bowel by capsule endoscopy in patients with UC.
Notes:
Akihiko Kusakabe, Akiko Sato, Ryuta Sugiura, Tomoko Koide, Masahiko Inamori (2011)  [The role of percutaneous endoscopic gastrostomy(PEG)in palliative care].   Gan To Kagaku Ryoho 38 Suppl 1: 85-86 Dec  
Abstract: The role of percutaneous endoscopic gastrostomy(PEG)in palliative care has not been well discussed. With the evolution of endoscopic techniques and PEG devices, we can perform PEG more safely, even in difficult cases. Actually, PEG is very useful in home care of cancer patients. We should discuss the indications of PEG in the field of palliative medicine. We suggest the following indications for PEG: 1.Difficulty in ingestion of sufficient quantities of food and water because of pain on swallowing, or an obstruction caused by cancer. 2.Normal gastrointestinal function. 3.Expected survival time of more than four weeks in addition to absence of cachexia. 4.Patient's consent for PEG.
Notes:
Yutaka Kawakami, Hirokazu Takahashi, Shingo Kato, Takashi Uchiyama, Hironori Mawatari, Hiroshi Iida, Masahiko Inamori, Yasunobu Abe, Atsushi Nakajima (2011)  Effective treatment for duodenal variceal bleeding using endoscopic ligation.   Hepatogastroenterology 58: 112. 2024-2025 Nov/Dec  
Abstract: Duodenal variceal rupture is rare, and there is little agreement on the best therapeutic option. A 72-year old man treated for liver cirrhosis with HCV visited the emergency room complaining of dizziness and tarry stool. Fiberscope images showed varices (F2CbRC+) with white plaques at the horizontal region of the duodenum. The patient was treated using endoscopic variceal ligation (EVL), and no more bleeding has been detected.
Notes:
Yasunari Sakamoto, Yusuke Sekino, Eiji Yamada, Hidenori Ohkubo, Takuma Higurashi, Eiji Sakai, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Takashi Nonaka, Tamon Ikeda, Koji Fujita, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori (2011)  Mosapride Accelerates the Delayed Gastric Emptying of High-Viscosity Liquids: A Crossover Study Using Continuous Real-Time C Breath Test (BreathID System).   J Neurogastroenterol Motil 17: 4. 395-401 Oct  
Abstract: The administration of liquid nutrients to patients is often accompanied by complications such as gastroesophageal reflux. To prevent gastroesophageal reflux, high-viscosity liquid meals are used widely, however, it still remains controversial whether high-viscosity liquid meals have any effect on the rate of gastric emptying. The present study was conducted with the aim of determining whether high-viscosity liquid meals had any effect on the rate of gastric emptying and mosapride might accelerate the rate of gastric emptying of high-viscosity liquid meals.
Notes:
Takashi Nonaka, Takaomi Kessoku, Yuji Ogawa, Kento Imajyo, Shogo Yanagisawa, Tadahiko Shiba, Takashi Sakaguchi, Kazuhiro Atsukawa, Hisao Takahashi, Yusuke Sekino, Eiji Sakai, Takashi Uchiyama, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Chikako Tokoro, Yasunobu Abe, Eiji Gotoh, Shin Maeda, Atsushi Nakajima, Masahiko Inamori (2011)  Effects of Histamine-2 Receptor Antagonists and Proton Pump Inhibitors on the Rate of Gastric Emptying: A Crossover Study Using a Continuous Real-Time C Breath Test (BreathID System).   J Neurogastroenterol Motil 17: 3. 287-293 Jul  
Abstract: The effects of Histamine-2 receptor antagonists and proton pump inhibitors on the gastrointestinal motility have not yet been sufficiently investigated. The aim of this study was to determine the effects of intravenous bolus administration of famotidine and omeprazole on the rate of gastric emptying using the continuous (13)C breath test (BreathID system, Exalenz Bioscience Ltd, Israel).
Notes:
Nobutaka Fujisawa, Masahiko Inamori, Yusuke Sekino, Keiko Akimoto, Hiroshi Iida, Ayako Takahata, Hiroki Endo, Kunihiro Hosono, Yasunari Sakamoto, Tomoyuki Akiyama, Tomoko Koide, Chikako Tokoro, Hirokazu Takahashi, Kumiko Saito, Yasunobu Abe, Atsushi Nakamura, Kensuke Kubota, Satoru Saito, Shigeru Koyama, Atsushi Nakajima (2011)  Risk factors for mortality in patients with Mallory-Weiss syndrome.   Hepatogastroenterology 58: 106. 417-420 Mar/Apr  
Abstract: Although the majority of patients with Mallory-Weiss syndrome (MWS) have a benign course, in some patients MWS results in a fatal outcome. Therefore, this study was carried out to analyze the risk factors for mortality in patients with MWS.
Notes:
Hiroki Endo, Takuma Higurashi, Kunihiro Hosono, Eiji Sakai, Yusuke Sekino, Hiroshi Iida, Yasunari Sakamoto, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Chikako Tokoro, Masahiko Inamori, Yasunobu Abe, Atsushi Nakajima (2011)  Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study.   J Gastroenterol 46: 7. 894-905 Jul  
Abstract: Few studies have investigated measures to prevent small bowel injuries induced by aspirin. Our aim was to evaluate the effect of probiotic treatment on the small bowel injuries induced by chronic low-dose aspirin use.
Notes:
Hideyuki Chiba, Masau Sekiguchi, Takafumi Ito, Yosuke Tsuji, Ken Ohata, Akiko Ohno, Shotaro Umezawa, Suguru Takeuchi, Kantaro Hisatomi, Takuma Teratani, Nobuyuki Matsuhashi, Hiroki Endo, Masahiko Inamori, Atsushi Nakajima (2011)  Is it worthwhile to perform capsule endoscopy for asymptomatic patients with positive immunochemical faecal occult blood test?   Dig Dis Sci 56: 12. 3459-3462 Dec  
Abstract: The immunochemical faecal occult blood test (IFOBT) is widely performed for colorectal cancer screening, but the usefulness of IFOBT in the detection of disorders of the small intestine is unknown. The objective of this study was to investigate what proportion of IFOBT-positive subjects with negative colonoscopy and oesophagogastroduodenoscopy has pathologies of the small intestine detected by capsule endoscopy (CE).
Notes:
Yusuke Sekino, Masahiko Inamori, Mitsuru Hirai, Kaori Suzuki, Kaoru Tsuzawa, Keiko Akimoto, Ayako Takahata, Nobutaka Fujisawa, Kumiko Saito, Akisa Tsunemi, Michio Tanaka, Hiroshi Iida, Yasunari Sakamoto, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Yasunobu Abe, Atsushi Nakajima, Shin Maeda, Shigeru Koyama (2011)  Solitary Peutz-Jeghers type hamartomatous polyps in the duodenum are not always associated with a low risk of cancer: two case reports.   J Med Case Reports 5: 1. Jun  
Abstract: ABSTRACT: Introduction A hamartomatous polyp without associated mucocutaneous pigmentation or a family history of Peutz-Jeghers Syndrome is diagnosed as a solitary Peutz-Jeghers type hamartomatous polyp. As compared with Peutz-Jeghers Syndrome, Peutz-Jeghers type hamartomatous polyps are diagnosed with a lower risk of cancer and are regarded as a different disorder. Case presentation In case one, we describe an 84-year-old Japanese man with a 14mm duodenal polyp. Endoscopic mucosal resection was performed and histological examination showed findings suggestive of a hamartomatous polyp with a focus of well-differentiated adenocarcinoma. In case two, we describe a 76-year-old Japanese man who had been treated for prostate, rectal and lung cancer. Upper gastrointestinal endoscopy revealed a duodenal polyp measuring 15mm in diameter. Endoscopic mucosal resection was performed, and histological examination showed findings suggestive of a hamartomatous polyp. Liver and thyroid cancers were found after the endoscopic treatment. Conclusion Although duodenal solitary hamartomatous polyps are associated with a lower risk of cancer, four patients, including our cases, have been diagnosed with cancerous polyps. Patients with duodenal solitary hamartomatous polyps should be treated by endoscopic or surgical resection and need whole-body screening.
Notes:
Yasunari Sakamoto, Shingo Kato, Yusuke Sekino, Eiji Sakai, Takashi Uchiyama, Hiroshi Iida, Kunihiro Hosono, Hiroki Endo, Koji Fujita, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Shin Maeda, Atsushi Nakajima, Masahiko Inamori (2011)  Change of gastric emptying with chewing gum: evaluation using a continuous real-time C breath test (BreathID system).   J Neurogastroenterol Motil 17: 2. 174-179 Apr  
Abstract: There are few reports on the correlation between chewing gum and the gastrointestinal functions. But previous report showed use of chewing gum to be an effective method for controlling gastrointestinal symptoms. The aim of this study was to determine the correlation between chewing gum and gastric emptying using the continuous real time (13)C breath test (BreathID system).
Notes:
2010
Kensuke Kubota, Tomoko Wada, Shingo Kato, Yuichi Mozaki, Masato Yoneda, Koji Fujita, Hirokazu Takahashi, Masahiko Inamori, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Satoru Saito, Yoshiaki Inayama, Atsushi Nakajima (2010)  Highly active state of autoimmune pancreatitis with mikulicz disease.   Pancreas 39: 1. e6-10 Jan  
Abstract: Patients with autoimmune pancreatitis (AIP) sometimes present with Mikulicz disease (MD); however, the clinical features regarding these AIP patients with MD have not yet been fully elucidated. Our aim is to study the clinical differences between AIP with and without MD.
Notes:
Kaori Suzuki, Hiroyuki Kirikoshi, Masato Yoneda, Hironori Mawatari, Koji Fujita, Yuichi Nozaki, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Takeshi Shimamura, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima (2010)  Measurement of spleen volume is useful for distinguishing between simple steatosis and early-stage non-alcoholic steatohepatitis.   Hepatol Res 40: 7. 693-700 Jul  
Abstract: Aim: Although non-alcoholic fatty liver disease (NAFLD) is now a common cause of chronic liver disease, discriminating between simple steatosis and non-alcoholic steatohepatitis (NASH), especially early-stage NASH, remains difficult. We investigated the clinical usefulness of measuring the spleen volume as a marker of early-stage NASH. Methods: We evaluated computed tomography (CT) images obtained in 84 patients with histologically diagnosed NAFLD (22 with simple steatosis, 62 with NASH with mild fibrosis [stages 1-2]). We defined the data obtained by the following formula as a spleen-body index (SBI): SBI = maximal CT axial section area of the spleen (cm(2))/body surface area (BSA) (cm(2)) x 10(4). We compared the SBI between patients with simple steatosis and those with NASH with mild fibrosis. Results: The mean SBI of the simple steatosis group was 15.8 +/- 3.9, while that of the NASH with mild fibrosis group was 18.7 +/- 5.7. This difference between the two groups was significant (P = 0.0314). A multiple logistic regression analysis showed that the SBI was significantly correlated with the discrimination of simple steatosis and NASH with mild fibrosis. The area under the receiver-operator curve was 0.661 for distinguishing between simple steatosis and NASH with mild fibrosis (P = 0.026, 95% confidence interval = 0.532-0.789). Conclusion: Spleen enlargement may be a distinct feature of NASH, especially early-stage NASH. SBI might be a non-invasive and simple method of differentiating NASH and simple steatosis.
Notes:
Kensuke Kubota, Shingo Kato, Hironori Mawatari, Hiroshi Iida, Tomoyuki Akiyama, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Masahiko Inamori, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Satoru Saito, Atsushi Nakajima (2010)  Risky endoscopic ultrasonography-guided fine-needle aspiration for asymptomatic retroperitoneal tumors.   Dig Endosc 22: 2. 144-146 Apr  
Abstract: Paraganglioma, a sporadically occurring rare tumor should be included in the differential diagnosis of retroperitoneal tumors, such as malignant lymphomas, gastrointestinal stromal tumors, sarcoma and carcinoma of unknown primary site. A 58-year-old Japanese woman presented with a large retroperitoneal tumor detected by ultrasonography (US). She had no medical history of hypertension. Computed tomography showed a mass, 7 cm in diameter, located between the pancreas and the inferior vena cava. It was unclear whether the mass originated from the duodenum or the mesentery. Endoscopic ultrasonography (EUS) demonstrated a large solid paraduodenal mass. Doppler US revealed sparse vascularity in the tumor. With the differential diagnosis of retroperitoneal tumor, we carried out EUS-FNA. At the time of the third needle puncture, transient severe hypertension was noted, with a blood pressure measurement of 269/130 mmHg. Data obtained from urine and blood examinations after EUS-fine-needle aspiration indicated a diagnosis of paraganglioma.
Notes:
Kunihiro Hosono, Hiroki Endo, Hirokazu Takahashi, Michiko Sugiyama, Takashi Uchiyama, Kaori Suzuki, Yuichi Nozaki, Kyoko Yoneda, Koji Fujita, Masato Yoneda, Masahiko Inamori, Akiko Tomatsu, Takeshi Chihara, Kan Shimpo, Hitoshi Nakagama, Atsushi Nakajima (2010)  Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.   Mol Carcinog 49: 7. 662-671 Jul  
Abstract: Metformin is widely used for the treatment of diabetes mellitus. Adenosine monophosphate-activated protein kinase (AMPK) is known to be activated by metformin and to inhibit the mammalian target of rapamycin (mTOR) pathway. The mTOR pathway plays an important role in the protein translational machinery and cell proliferation. We examined the effect of metformin on the suppression of colorectal carcinogenesis in chemical carcinogen-induced models. Seven-wk-old BALB/c mice were intraperitoneally (i.p.) injected with azoxymethane (AOM, 10 mg/kg) and then treated with or without metformin (250 mg/kg/d) for 6 wk (for the investigation of aberrant crypt foci [ACF] formation) or 32 wk (for polyp formation). We next investigated colonic epithelial proliferation using bromodeoxyuridine (BrdU) and the proliferating cell nuclear antigen (PCNA) labeling indices. Furthermore, to examine the indirect effect of metformin, the insulin resistance status and the serum lipid levels were assessed. Treatment with metformin significantly reduced ACF formation. The effect of metformin on colon polyp inhibition was relatively modest. No significant difference in body weight or glucose concentration was observed. The BrdU and PCNA indices decreased in mice treated with metformin. A Western blot analysis revealed that the phosphorylated mTOR, S6 kinase, and S6 protein levels in the colonic mucosa decreased significantly in mice treated with metformin. In conclusion, metformin suppresses colonic epithelial proliferation via the inhibition of the mTOR pathway through the activation of AMPK. As metformin is already used daily as an antidiabetic drug, it might be a safe and promising candidate for the chemoprevention of colorectal cancer.
Notes:
H Mawatari, M Yoneda, K Fujita, Y Nozaki, Y Shinohara, H Sasaki, H Iida, H Takahashi, M Inamori, Y Abe, N Kobayashi, K Kubota, H Kirikoshi, A Nakajima, S Saito (2010)  Association between phospholipids and free cholesterol in high-density lipoprotein and the response to hepatitis C treatment in Japanese with genotype 1b.   J Viral Hepat 17: 12. 859-865 Dec  
Abstract: Pegylated interferon and ribavirin combination therapy is the standard treatment for patients with chronic hepatitis C (CHC), but treatment failure can be difficult to predict. We and others have reported a relation between lipid values and sustained viral responses in patients with CHC. However, the relationship between lipid values and treatment failure has not been previously reported. The present study investigated the association between the profiles of phospholipids and free cholesterol (FC), the main constitutive ingredients of the surface of lipoprotein, classified according to particle size and hepatitis C treatment, and determined the usefulness of these parameters for predicting the outcome of treatment. Fifty-five patients with CHC (33 men and 22 women) were included in the study. The serum total cholesterol, triglyceride, phospholipids, and FC levels in the lipoprotein subclasses were determined using high-performance liquid chromatography with gel permeation columns, enabling the lipoproteins to be classified into 13 subclasses according to particle size. According to a univariate analysis, the treatment failure group had a significantly higher serum phospholipid level overall in the high-density lipoprotein (HDL) and medium HDL fractions as well as a higher serum FC level in the HDL fraction and all HDL subclass fractions compared with the corresponding values in the non-nonvirological response group. Higher serum phospholipid and FC concentrations in the HDL subclasses were predictive of a failure to respond in patients with genotype 1b.
Notes:
T Uchiyama, Takahashi Hirokazu, K Hosono, H Endo, T Akiyama, K Yoneda, M Inamori, Y Abe, K Kubota, S Saito, A Nakajima (2010)  Portal vein thrombosis treated using danaparoid sodium and antithrombin III.   Hepatogastroenterology 57: 97. 52-53 Jan/Feb  
Abstract: A 45-year-old man under treatment for liver cirrhosis (LC) due to chronic hepatitis C and hemophilia A was seen in our emergency room because of a 10-kg weight gain in the previous week due to ascites. Portal vein thrombosis (PVT) was detected with computer tomography (CT) and ultrasonographic (US). Danaparoid sodium (DS) and antithrombin III (AT III) were administrated and doppler US images showed improvement of portal venous blood flow. DS or AT III may be safe and alternative therapies for PVT.
Notes:
Azusa Nagasaki, Hirokazu Takahashi, Mizue Iinuma, Takashi Uchiyama, Seitaro Watanabe, Tomoko Koide, Chikako Tokoro, Masahiko Inamori, Yasunobu Abe, Atsushi Nakajima (2010)  Ulcerative colitis with multidrug-resistant Pseudomonas aeruginosa infection successfully treated with bifidobacterium.   Digestion 81: 3. 204-205 01  
Abstract: A 71-year-old man was diagnosed with ulcerative colitis (UC) complicated by bacterial infections, and his active disease proved difficult to treat with steroid therapy or antibiotics. Although the patient's UC failed to respond to several types of induction therapy, his condition finally improved when treated using Bifidobacterium. Probiotics could be one of the treatment agents for induction of remission in UC.
Notes:
Masato Yoneda, Koji Fujita, Yuichi Nozaki, Hiroki Endo, Hirokazu Takahashi, Kunihiro Hosono, Kaori Suzuki, Hironori Mawatari, Hiroyuki Kirikoshi, Masahiko Inamori, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Kensuke Kubota, Shiro Maeyama, Atsushi Nakajima (2010)  Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study.   Hepatol Res 40: 6. 613-621 Jun  
Abstract: Aim: Non-alcoholic steatohepatitis (NASH) is considered a hepatic manifestation of metabolic syndrome. However, effective drug therapy for NASH has not been established yet. In the present study, we evaluated the efficacy of 6 months of ezetimibe treatment for NASH patients with dyslipidemia for the comparison of improvement of the clinical parameters and histological alterations. Methods: We prospectively evaluated 10 consecutive NASH patients with dyslipidemia who agreed to participate in this study. The patients were given ezetimibe (10 mg/day) for 6 months, and clinical parameters and histological alterations were comparatively evaluated before and after treatment. All the patients were given standard calorie diet (30 kcal/kg per day, carbohydrate 50-60%, fat 20-30%, protein 15-20%) and exercise counseling from 3 months before the ezetimibe treatment. Results: The serum aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transpeptidase, low-density lipoprotein cholesterol, high-sensitivity C-reactive protein and type IV collagen 7 s levels were significantly improved by the treatment with ezetimibe for 6 months. In histological observations, follow-up liver biopsies revealed that the NAS score and steatosis grade were also significantly improved. The fibrosis stage did not change significantly, but six of the 10 patients exhibited an improvement in their fibrosis stage. Conclusion: Major clinical parameters and histological observations were significantly improved by the treatment with ezetimibe. Our pilot study demonstrated the efficacy of ezetimibe for drug therapy of NASH and may lead to a large-scale clinical trial in the future.
Notes:
Tomoyuki Akiyama, Masahiko Inamori, Keiko Akimoto, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Tamon Ikeda, Yasunari Sakamoto, Koji Fujita, Masato Yoneda, Tomoko Koide, Hirokazu Takahashi, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Akihiko Moriya, Yasushi Rino, Toshio Imada, Atsushi Nakajima (2010)  Gastric surgery is not a risk factor for erosive esophagitis or Barrett's esophagus.   Scand J Gastroenterol 45: 4. 403-408 Apr  
Abstract: The role of gastric acid reflux is difficult to separate from that of pancreatic-biliary reflux in the pathogenesis of erosive esophagitis (EE) and Barrett's esophagus (BE). Gastric surgery patients provide a good model for both significant pancreatic-biliary reflux and marked gastric acid inhibition. We assessed the risk of EE and BE after distal gastrectomy in a case-controlled study.
Notes:
Chikako Tokoro, Masahiko Inamori, Tomoko Koide, Hiroshi Iida, Yasunari Sakamoto, Hiroki Endo, Kunihiro Hosono, Hirokazu Takahashi, Masato Yoneda, Hiroaki Yasuzaki, Masami Ogawa, Yasunobu Abe, Kensuke Kubota, Satoru Saitou, Ichiro Kawana, Reikei Matsuda, Daisuke Takahashi, Atsushi Nakajima (2010)  Does pretreatment with proton pump inhibitors influence the eradication rate of Helicobacter pylori?   Hepatogastroenterology 57: 104. 1645-1649 Nov/Dec  
Abstract: Pretreatment with a proton pump inhibitor (PPI) has been reported to decrease the efficacy of Helicobacter pylori (H. pylori) eradication. We compared the efficacy of an eradication regimen (lansoprazole/amoxicillin/clarithromycin) first or following pretreatment with a PPI.
Notes:
Kazuhisa Okada, Masahiko Inamori, Kento Imajyo, Hideyuki Chiba, Takashi Nonaka, Tadahiko Shiba, Takashi Sakaguchi, Kazuhiko Atsukawa, Hisao Takahashi, Etsuo Hoshino, Atsushi Nakajima (2010)  Gender differences of low-dose aspirin-associated gastroduodenal ulcer in Japanese patients.   World J Gastroenterol 16: 15. 1896-1900 Apr  
Abstract: To clarify the gender differences about the clinical features and risk factors of low-dose aspirin (LDA) (81-100 mg daily)-associated peptic ulcer in Japanese patients.
Notes:
Tomoko Koide, Masahiko Inamori, Akihiho Kusakabe, Takashi Uchiyama, Seitaro Watanabe, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Yasunari Sakamoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Chikako Tokoro, Hiroaki Yasuzaki, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nahajima (2010)  Early complications following percutaneous endoscopic gastrostomy: results of use of a new direct technique.   Hepatogastroenterology 57: 104. 1639-1644 Nov/Dec  
Abstract: Percutaneous endoscopic gastrostomy is the standard method for enteral feeding in patients predicted to require long-term enteral nutrition because of dysphagia. A direct techinique with gastropexy is available, in which oropharyngeal passage of the internal bumper can be avoided. The aim of this study was to assess the early complications of percutaneous endoscopic gastrostomy performed using the new direct technique.
Notes:
H Mawatari, M Yoneda, K Fujita, Y Nozaki, Y Shinohara, H Sasaki, H Iida, H Takahashi, M Inamori, Y Abe, N Kobayashi, K Kubota, H Kirikoshi, A Nakajima, S Saito (2010)  Association between lipoprotein subfraction profile and the response to hepatitis C treatment in Japanese patients with genotype 1b.   J Viral Hepat 17: 4. 274-279 Apr  
Abstract: Pegylated interferon and ribavirin combination therapy is the standard treatment for patients with chronic hepatitis C (CHC). Some groups have reported a relation between lipid values and response while others have reported that microsomal triglyceride transfer protein, a key enzyme in the assembly and secretion of lipoproteins, was related to hepatitis C virus (HCV). The aim of this study was to investigate the association between the lipoprotein profiles, classified according to size, and hepatitis C treatment and the usefulness for predicting the outcome of treatment. Forty-four patients with CHC (27 men and 17 women) were included in the study. The serum cholesterol and triglyceride (TG) levels in the lipoprotein subclasses were determined using high-performance liquid chromatography with gel permeation columns, which classified lipoproteins into 20 subfractions based on particle size. According to a univariate analysis, those who achieved an sustained viral response (SVR) had a significantly higher serum total cholesterol level, higher cholesterol levels in the low-density lipoprotein subfraction (25.5 nm in diameter) and the very low-density lipoprotein (VLDL) subfraction (44.5 and 36.8 nm), and a higher serum TG level in the VLDL subfraction (44.5 nm), compared with the corresponding values in the non-SVR group. Higher serum cholesterol and TG concentrations in the lipoprotein subfractions were predictive of an SVR to therapy for HCV infection with genotype 1b prior to the start of interferon treatment.
Notes:
Masato Yoneda, Yuichi Nozaki, Hiroki Endo, Hironori Mawatari, Hiroshi Iida, Koji Fujita, Kyoko Yoneda, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Shiro Maeyama, Kikuko Hotta, Atsushi Nakajima (2010)  Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation.   Dig Dis Sci 55: 3. 808-814 Mar  
Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver injury. The spectrum of NAFLD is broad, extending from simple steatosis through nonalcoholic steatohepatitis (NASH). Iron is regarded as a putative element that interacts with oxygen radicals, and high rates of hyperferritinemia and increased hepatic iron stores have been demonstrated in NASH. We investigated serum ferritin concentrations, HFE gene mutations, and insulin resistance in Japanese NASH patients and the diagnostic utility of serum ferritin concentrations as a means of distinguishing NASH. Serum ferritin concentrations were measured in 86 patients with histopathologically verified NAFLD (24 with steatosis and 62 with NASH) and 20 control subjects, they were tested for HFE gene mutations and their insulin resistance was measured. The serum ferritin concentration was significantly higher in the NASH patients than in the patients with simple steatosis (P = 0.006). There was no significant difference between the groups in HFE gene mutation (C282Y, H63D, and S65C), and the serum ferritin level was related with insulin resistance. The area under the ROC curve was 0.732 for distinguishing NASH from simple steatosis (P = 0.005; 95% CI, 0.596-0.856). In conclusion high serum ferritin concentrations are a distinguishing feature of Japanese NASH patients independent of HFE gene mutations.
Notes:
Koji Fujita, Yuichi Nozaki, Masato Yoneda, Koichiro Wada, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Shiro Maeyama, Atsushi Nakajima (2010)  Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model.   Alcohol Clin Exp Res 34 Suppl 1: S18-S24 Feb  
Abstract: The pathogenesis of nonalcoholic steatohepatitis (NASH) is still unclear. Recently, the 2-hit hypothesis was proposed, in which nitric oxide production, representing oxidative stress, was proposed as a very important candidate for the second hit.
Notes:
Masahiko Inamori, Hiroshi Iida, Kunihiro Hosono, Hirohi Endo, Yasunari Sakamoto, Hirohazu Takahashi, Tomoko Koide, Chikako Tokoro, Ayumu Goto, Yasunobu Abe, Noboru Hiratsuka, Atsushi Nakajima, Masami Fujita (2010)  The histamine H2 receptor antagonist lafutidine in Japanese patients with non-erosive reflux disease.   Hepatogastroenterology 57: 104. 1430-1434 Nov/Dec  
Abstract: This study aims to investigate whether histamine H2-receptor antagonists are sufficient to treat nonerosive reflux disease in Japanese patients. The efficacy of lafutidine in Japanese nonerosive reflux disease patients was studied.
Notes:
Kunihiro Hosono, Hiroki Endo, Hirokazu Takahashi, Michiko Sugiyama, Eiji Sakai, Takashi Uchiyama, Kaori Suzuki, Hiroshi Iida, Yasunari Sakamoto, Kyoko Yoneda, Tomoko Koide, Chikako Tokoro, Yasunobu Abe, Masahiko Inamori, Hitoshi Nakagama, Atsushi Nakajima (2010)  Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.   Cancer Prev Res (Phila) 3: 9. 1077-1083 Sep  
Abstract: The biguanide metformin is widely used for treating diabetes mellitus. We previously showed the chemopreventive effect of metformin in two rodent models of colorectal carcinogenesis. However, besides epidemiologic studies, little is known about the effects of metformin on human colorectal carcinogenesis. The objective of this pilot study was to evaluate the chemopreventive effect of metformin on rectal aberrant crypt foci (ACF), which are an endoscopic surrogate marker of colorectal cancer. We prospectively randomized 26 nondiabetic patients with ACF to treatment with metformin (250 mg/d, n = 12) or no treatment (control, n = 14); 23 patients were evaluable for end point analyses (9 metformin and 14 control); the two groups were similar in ACF number and other baseline clinical characteristics. Magnifying colonoscopy determined the number of rectal ACF in each patient at baseline and after 1 month in a blinded fashion (as were all laboratory end point analyses). We also examined proliferative activity in colonic epithelium (via proliferating cell nuclear antigen labeling index) and apoptotic activity (via terminal deoxynucleotidyl transferase dUTP nick-end labeling). At 1 month, the metformin group had a significant decrease in the mean number of ACF per patient (8.78 +/- 6.45 before treatment versus 5.11 +/- 4.99 at 1 month, P = 0.007), whereas the mean ACF number did not change significantly in the control group (7.23 +/- 6.65 versus 7.56 +/- 6.75, P = 0.609). The proliferating cell nuclear antigen index was significantly decreased and the apoptotic cell index remained unaltered in normal rectal epithelium in metformin patients. This first reported trial of metformin for inhibiting colorectal carcinogenesis in humans provides preliminary evidence that metformin suppresses colonic epithelial proliferation and rectal ACF formation in humans, suggesting its promise for the chemoprevention of colorectal cancer.
Notes:
Hirohisa Imai, H Nakao, H Shinohara, Y Fujii, H Tsukino, R Hamasuna, Y Osada, K Fukushima, M Inamori, T Ikenoue, T Katoh (2010)  Population-based study of asymptomatic infection with Chlamydia trachomatis among female and male students.   Int J STD AIDS 21: 5. 362-366 May  
Abstract: There are few epidemiological studies of asymptomatic chlamydial infection among students in non-medical settings with minimal bias and improved accuracy; thus, useful data from screening among students are limited. We aimed to obtain accurate epidemiological information about asymptomatic chlamydial infection among students in non-medical settings. A population-based cross-sectional survey of 10,440 >or=18-year-old asymptomatic students who volunteered for a urine screening test for chlamydia was conducted. The prevalences of asymptomatic infection were 9.5% for women and 6.7% for men. Multivariate analysis revealed the risk factors to be a lifetime history of >or=4 sexual partners for women (odds ratio [OR] 3.17) and inconsistent condom use for men (OR 4.18). For both sexes, younger age at first intercourse was associated with a higher rate of inconsistent condom use. This study produced accurate epidemiological information on asymptomatic chlamydial infection. These results may contribute to the establishment of preventive countermeasures against such infection.
Notes:
Y Kawakami, H Takahashi, H Mawatari, L Taniguchi, K Hosono, H Endo, K Yoneda, M Inamori, Y Abe, A Nakajima (2010)  Gastric variceal rupture successfully treated with repeated EIS and EVL.   Hepatogastroenterology 57: 98. 377-378 Mar/Apr  
Abstract: A 68-year-old female with liver cirrhosis presented at the Emergency Room of our hospital with copious tarry stools. Upper gastrointestinal endoscopy showed an isolated gastric variceal rupture, and we performed endoscopic injection sclerotherapy using cyanoacrylate, on four occasions, resulting in successful hemostasis. Injection of CA is a useful emergency treatment option for gastric variceal bleeding without gastro-renal shunt.
Notes:
2009
Kazuhisa Okada, Masahiko Inamori, Kento Imajo, Hideyuki Chiba, Takashi Nonaka, Tadahiko Shiba, Takashi Sakaguchi, Kazuhiro Atsukawa, Hisao Takahashi, Etsuo Hoshino, Atsushi Nakajima (2009)  Clinical study of upper gastrointestinal bleeding associated with low-dose aspirin in Japanese patients.   Hepatogastroenterology 56: 96. 1665-1669 Nov/Dec  
Abstract: The aim of this study was to clarify the prevalence and various clinical factors of upper gastrointestinal bleeding (UGIB) associated with low-dose aspirin (LDA) treatment.
Notes:
Hirokazu Takahashi, Tetsuji Takayama, Kunihiro Hosono, Kyoko Yoneda, Hiroki Endo, Yuichi Nozaki, Koji Fujita, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Hitoshi Nakagama, Atsushi Nakajima (2009)  Correlation of the plasma level of insulin-like growth factor-1 with the number of aberrant crypt foci in male individuals.   Mol Med Report 2: 3. 339-343 May/Jun  
Abstract: In human subjects, aberrant crypt foci (ACF) can be classified as dysplastic or non-dysplastic using magnifying colonoscopy. Dysplastic ACF are thought to be a biomarker for the risk of colorectal cancer (CRC). Hyperinsulinemia and insulin-like growth factor-1 (IGF-1) have also been reported to be associated with an increased risk of CRC. To clarify this association, we investigated the relationship between diabetes risk, IGF-1 and the number of dysplastic ACF. Assessment of the number of dysplastic ACF in the entire colorectum is technically difficult, and we imaged the lower rectum only. Blood collections were taken in the morning on the day of colonoscopy. A total of 512 ACF were counted in 84 male participants, and a correlation was demonstrated to exist between age, body mass index (BMI), fasting blood sugar (FBS), insulin, homeostasis model assessment-insulin resistance (HOMA-IR), plasma leptin levels, plasma IGF-1 levels and the number of dysplastic ACF. A significant association between plasma IGF-1 levels and the number of dysplastic ACF was still demonstrable after adjustment for age, BMI, FBS, insulin, HOMA-IR and plasma leptin levels. Our findings suggest that increased plasma leptin and IGF-1 levels, hyper-insulinemia and insulin resistance may promote the growth of dysplastic ACF. The results of multiple regression analysis revealed that increased plasma IGF-1 levels are associated with the number of dysplastic ACF present, and may be an independent risk factor for CRC. In conclusion, elevated plasma IGF-1 may promote the growth of dysplastic ACF and play a key role in colon carcinogenesis in male individuals.
Notes:
Tomoyuki Akiyama, Masahiko Inamori, Takeshi Shimamura, Hiroshi Iida, Hiroki Endo, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Hiroshi Kobayashi, Shoji Yamanaka, Yasushi Rino, Atsushi Nakajima (2009)  Penetration of the sigmoid colon to the posterior uterine wall secondary to diverticulitis: a case report.   J Med Case Reports 3: 08  
Abstract: ABSTRACT : INTRODUCTION : Penetration of the colon to the posterior uterine wall secondary to diverticulitis is unusual, with diagnostic methods not yet established. Non-invasive imaging, such as computed tomography and magnetic resonance imaging may help to establish a proper diagnosis, but confirmation may be reached only after surgical exploration. CASE PRESENTATION : We report the case of a 78-year-old Japanese woman who presented with a low grade fever and mild diarrhea which occurred two or three times a week. Computed tomography and magnetic resonance imaging demonstrated a capsular lesion including an air structure with a diameter of 5 cm, between the posterior aspect of the uterine body and the sigmoid colon. A gastrograffin enema and colonoscopy demonstrated a giant diverticulum of the sigmoid colon with no evidence of malignancy. These data confirmed the diagnosis of diverticulitis complicated by a giant diverticulum. Because of a relapsing fever after therapy with antibiotics, the patient had en bloc surgical treatment of the uterus, fallopian tubes, ovaries and sigmoid colon, the organs involved in the diverticulitis, followed by an uneventful recovery. CONCLUSION : This is a rare case report of penetration of the sigmoid colon to the posterior uterine wall secondary to diverticulitis.
Notes:
Kumiko Saito, Masahiko Inamori, Yusuke Sekino, Keiko Akimoto, Kaori Suzuki, Ayako Tomimoto, Nobutaka Fujisawa, Kensuke Kubota, Satoru Saito, Shigeru Koyama, Atsushi Nakajima (2009)  Management of acute lower intestinal bleeding: what bowel preparation should be required for urgent colonoscopy?   Hepatogastroenterology 56: 94-95. 1331-1334 Sep/Oct  
Abstract: The management of acute intestinal bleeding is not standardized. The aim of this study was to determine the most suitable method of bowel preparation for urgent colonoscopy.
Notes:
Hironori Mawatari, Masahiko Inamori, Koji Fujita, Masato Yoneda, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Yuichi Nozaki, Kyoko Yoneda, Tomoyuki Akiyama, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima (2009)  The continuous real-time 13C-octanoate breath test for patients with nonalcoholic steatohepatitis using the BreathID system.   Hepatogastroenterology 56: 94-95. 1436-1438 Sep/Oct  
Abstract: Hepatic mitochondrial beta-oxidation is considered to play a pivotal role in the pathogenesis of nonalcoholic steatohepatitis (NASH). The aim of this study was to determine whether there were differences between patients with NASH and healthy controls in a breath test with 13C-octanoate, a medium-chain fatty acid. Methodology: The subjects were 8 patients (5 men, 3 women, median age 46.5 years) with histologically proven NASH and 6 healthy controls (5 men, 1 women, and median age 27.8 years). The 13C breath test was performed for 4 hours using the BreathID system with a 100 mL of water containing 100 mg 13C-octanoate.
Notes:
Hiroki Endo, Kunihiro Hosono, Masahiko Inamori, Yuichi Nozaki, Kyoko Yoneda, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Tomohiko Ohya, Kantaro Hisatomi, Takuma Teratani, Nobuyuki Matsuhashi, Atsushi Nakajima (2009)  Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy.   J Gastroenterol 44: 6. 544-549 04  
Abstract: The antithrombotic effects of low-dose aspirin (LDA) are well established, and it is used for primary and secondary prevention of cardiovascular events. However, the small intestinal toxicity of LDA remains unclear. The aim of this study was to review the characteristics of small bowel injury in long-term LDA users with capsule endoscopy (CE).
Notes:
Hiroki Endo, Nobuyuki Matsuhashi, Masahiko Inamori, Tomohiko Ohya, Hiroshi Iida, Hironori Mawatari, Yuichi Nozaki, Kyoko Yoneda, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima (2009)  Abdominal surgery affects small bowel transit time and completeness of capsule endoscopy.   Dig Dis Sci 54: 5. 1066-1070 May  
Abstract: The aim of the study was to evaluate bowel dysmotility in patients with a history of abdominal surgery by measuring both gastric transit time and small bowel transit time during capsule endoscopy and assessing the completeness of the examination. The study included 26 patients who had undergone abdominal surgery (postoperative group) and 52 patients who had not (control group). The capsule reached the cecum in 50.0% of the postoperative group and 80.8% of the control group (P=0.005). While there was no significant difference in gastric transit time between the two groups (P=0.882), small bowel transit time was significantly longer in the postoperative group (338.3+/-119.2 min) than in the control group (266.4+/-110.8 min, P=0.010). This is the first study to report that the small bowel transit time during capsule endoscopy is prolonged in patients who had a history of abdominal surgery, resulting in a lower frequency of complete examination.
Notes:
Hiroyuki Kirikoshi, Satoru Saito, Masato Yoneda, Koji Fujita, Hironori Mawatari, Takashi Uchiyama, Takuma Higurashi, Kento Imajo, Takashi Sakaguchi, Kazuhiro Atsukawa, Aya Sawabe, Akira Kanesaki, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Norio Ueno, Atsushi Nakajima (2009)  Outcomes and factors influencing survival in cirrhotic cases with spontaneous rupture of hepatocellular carcinoma: a multicenter study.   BMC Gastroenterol 9: 04  
Abstract: Spontaneous rupture is rare complication of hepatocellular carcinoma (HCC) with high mortality rate in cirrhotic cases. The aim of this study was to determine the factors influencing prognosis in cases of spontaneously ruptured HCC and to investigate the outcomes of the treatments employed, especially transcatheter arterial embolization (TAE).
Notes:
Tomoyuki Akiyama, Masahiko Inamori, Keiko Akimoto, Hiroshi Iida, Hironori Mawatari, Hiroki Endo, Yuichi Nozaki, Kyoko Yoneda, Yasunari Sakamoto, Tamon Ikeda, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima (2009)  Gender differences in the age-stratified prevalence of erosive esophagitis and Barrett's epithelium in Japan.   Hepatogastroenterology 56: 89. 144-148 Jan/Feb  
Abstract: In contrast to Western countries where erosive esophagitis (EE) is more prevalent in males, there is a high incidence of EE in elderly females in Japan. We aimed to examine the gender differences in the age-stratified prevalence of EE and Barrett's epithelium.
Notes:
Tomoyuki Akiyama, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Kyoko Yoneda, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Yasushi Rino, Atsushi Nakajima (2009)  Macroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in Japan.   BMC Gastroenterol 9: 05  
Abstract: We aimed to estimate whether the macroscopic extent of gastric mucosal atrophy is associated with a risk for esophageal squamous cell carcinoma using a case-control study in Japanese subjects, a population known to have a high prevalence of CagA-positive H. pylori infection.
Notes:
Hiroki Endo, Kunihiro Hosono, Masahiko Inamori, Shingo Kato, Yuichi Nozaki, Kyoko Yoneda, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Nobuyuki Matsuhashi, Atsushi Nakajima (2009)  Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers.   Digestion 79: 1. 44-51 02  
Abstract: Small intestinal toxicity of low-dose aspirin remains unclear. The purpose of this capsule endoscopy study was to assess the incidence of small bowel injury in healthy volunteers treated with short-term low-dose aspirin.
Notes:
Hirokazu Takahashi, Tetsuji Takayama, Kyoko Yoneda, Hiroki Endo, Hiroshi Iida, Michiko Sugiyama, Koji Fujita, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Satoru Saito, Koichiro Wada, Hitoshi Nakagama, Atsushi Nakajima (2009)  Association of visceral fat accumulation and plasma adiponectin with rectal dysplastic aberrant crypt foci in a clinical population.   Cancer Sci 100: 1. 29-32 Jan  
Abstract: The association between obesity and the risk of colorectal cancer (CRC) cannot be easily evaluated because CRC itself is associated with a gradual loss of bodyweight. Aberrant crypt foci (ACF) can be classified as dysplastic ACF or non-dysplastic ACF by magnifying colonoscopy, and dysplastic ACF are thought to be a biomarker of CRC. Ninety-four participants who underwent colonoscopy at Yokohama City University Hospital, Japan, were enrolled in the current study. We detected 557 ACF, including 67 dysplastic ACF (12.0%). Univariate regression analysis was conducted to determine correlations between the number of dysplastic ACF and various potential risk factors, including patient age, waist circumference, body mass index, visceral fat area (VFA), and plasma adiponectin level. The results of multiple regression analysis revealed that the number of dysplastic ACF correlated with age (correlation coefficient r=0.212, P=0.0383) and plasma adiponectin level (r=-0.201, P=0.0371), even after adjustments for sex, waist circumference, body mass index, and VFA. Our univariate correlation analysis data showed a significant correlation with the number of dysplastic ACF with VFA (r=0.238, P=0.0209), no correlation with subcutaneous fat area, and an inverse correlation with the plasma level of adiponectin (r=-0.258, P=0.0118). Thus, our results suggest that aging and visceral fat accumulation could correlate moderately with colorectal carcinogenesis. The novelty of our study lies in the finding that visceral fat accumulation and a low plasma adiponectin level may promote colorectal carcinogenesis; therefore, these obesity-related parameters may serve as novel targets for CRC prevention.
Notes:
M Inamori, H Iida, H Endo, K Hosono, T Akiyama, K Yoneda, K Fujita, T Iwasaki, H Takahashi, M Yoneda, A Goto, Y Abe, N Kobayashi, K Kubota, A Nakajima (2009)  Aperitif effects on gastric emptying: a crossover study using continuous real-time 13C breath test (BreathID System).   Dig Dis Sci 54: 4. 816-818 Apr  
Abstract: The aim of this study was to determine whether there is a correlation between aperitif and gastric emptying. Ten healthy male volunteers participated in this randomized, two-way crossover study. Under two conditions (after drinking an aperitif versus not), the (13)C breath test was performed for 4 h with a liquid meal (200 kcal/200 ml) containing 100 mg (13)C acetate. We used 50 ml of umeshu as the aperitif. This is a traditional Japanese plum liqueur, and contains 7 ml alcohol (14%). In the aperitif group, T(1/2), T(lag), and T(peak) were significantly delayed [T(1/2) (132: 113-174) versus (112: 92-134) (P = 0.0069); T(lag) (80: 63-94) versus (55: 47-85) (P = 0.0069); and T(peak) (81: 62-96) versus (54: 34-84) (P = 0.0069), (median: range, aperitif versus control, min)]. Gastric emptying was significantly delayed in the aperitif group as compared with the control group. This study revealed that even a small amount of alcohol such as an aperitif may contribute to delayed gastric emptying.
Notes:
Akiko Danjo, Kanako Yamaguchi, Kazuma Fujimoto, Toshihito Saitoh, Masahiko Inamori, Takashi Ando, Tomohiko Shimatani, Kyoichi Adachi, Fukunori Kinjo, Shiko Kuribayashi, Shoji Mitsufuji, Yasuhiro Fujiwara, Shigeki Koyama, Junichi Akiyama, Atsushi Takagi, Noriaki Manabe, Hiroto Miwa, Yasuyuki Shimoyama, Motoyasu Kusano (2009)  Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres.   J Gastroenterol Hepatol 24: 4. 633-638 Apr  
Abstract: We compared endoscopic findings of the frequency scale for the symptoms of gastroesophageal reflux disease (FSSG), a written questionnaire developed in Japan, to that for the questionnaire for the diagnosis of reflux esophagitis (QUEST) for the diagnosis of reflux esophagitis.
Notes:
Kyoko Yoneda, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Tomoyuki Akiyama, Hirokazu Takahashi, Masahiko Inamori, Yasunobu Abe, Masato Yoneda, Koji Fujita, Shingo Kato, Yuichi Nozaki, Yasushi Ichikawa, Hiroshi Uozaki, Masashi Fukayama, Takahiro Shimamura, Tatsuhiko Kodama, Hiroyuki Aburatani, Chihiro Miyazawa, Keisuke Ishii, Naoki Hosomi, Mina Sagara, Masazumi Takahashi, Hideyuki Ike, Hiroaki Saito, Akihiko Kusakabe, Atsushi Nakajima (2009)  Identification of Cystatin SN as a novel tumor marker for colorectal cancer.   Int J Oncol 35: 1. 33-40 Jul  
Abstract: The goal of this study was to investigate Cystatin SN, a cysteine protease inhibitor, as a novel tumor marker for colorectal cancer (CRC). Gene expression profiles of mRNA from normal tissues and cancer cell lines were performed. Twenty-eight monoclonal antibodies for Cystatin SN were generated and serum Cystatin SN was quantified using ELISA in sera from 159 patients with CRC and 40 healthy controls. Cystatin SN was highly expressed in colon cancer cells. Employing a receiver-operating characteristic curve, we obtained an area under the curve of 0.708 for Cystatin SN, 0.819 for carcinoembryonic antigen (CEA) and 0.703 for carbohydrate antigen 19-9 (CA19-9). The combination assay of Cystatin SN, CEA and CA19-9 showed 62.9% sensitivity and 90.0% specificity. Especially, the sensitivity of the combination assay in stages I and II detection, in which stages curative operation would be possible, was improved over that of the assay testing only for CEA and CA19-9 (from 37.5 to 42.5% in stage I, from 49.0 to 60.8% in stage II). Furthermore, Western blot analysis revealed that Cystatin SN was increased in the urine from patients with CRC. Our results suggest the possibility of utilizing this novel tumor marker that can be tested in urine samples. These observations suggest that Cystatin SN in combination with CEA and CA19-9 is a useful tumor marker for detecting early stage CRC and that it is a unique urinary excretory protein, suggesting that Cystatin SN might be a novel candidate for use in mass screening for CRC.
Notes:
Masato Yoneda, Kikuko Hotta, Yuichi Nozaki, Hiroki Endo, Takashi Uchiyama, Hironori Mawatari, Hiroshi Iida, Shingo Kato, Koji Fujita, Hirokazu Takahashi, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Masahiko Inamori, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Shiro Maeyama, Koichiro Wada, Atsushi Nakajima (2009)  Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease.   Liver Int 29: 7. 1078-1085 Aug  
Abstract: Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver injury in many countries. Genetic factors are important for the development of NAFLD, as well as environmental factors. Recently an angiotensin II type 1 receptor (AGTR1) has been recognized as important in the aetiology of fibrosis in the liver.
Notes:
Masato Yoneda, Kikuko Hotta, Yuichi Nozaki, Hiroki Endo, Wataru Tomeno, Seitaro Watanabe, Kunihiro Hosono, Hironori Mawatari, Hiroshi Iida, Koji Fujita, Hirokazu Takahashi, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Masahiko Inamori, Kensuke Kubota, Takeshi Shimamura, Satoru Saito, Shiro Maeyama, Koichiro Wada, Atsushi Nakajima (2009)  Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease.   Hepatol Res 39: 10. 963-971 Oct  
Abstract: Aim: Genetic factors as well as environmental factors play an important role in the development of non-alcoholic fatty liver disease (NAFLD). Recently, inducible nitric oxide synthase (iNOS) was significantly higher in the severest form of non-alcoholic steatohepatitis (NASH), and nitric oxide (NO) has been determined to play an important role in the process of fibrosis in NASH. In this study, we investigated iNOS gene polymorphisms for associations with NAFLD. Methods: A total of 115 NAFLD patients, consisting of 65 patients with NASH and 50 patients with simple steatosis, in whom a positive diagnosis had been made by liver biopsy, and 435 healthy control subjects, were recruited into this study. Results: We investigated 10 single nucleotide polymorphisms (SNP) of the iNOS gene, one of which, rs1060822, had the lowest P-value in the allele frequency model (P = 0.00078) with an odds ratio (95% confidence interval) of 0.49 (0.32-0.75). Four SNP, rs2297510, rs2297511, rs2797512 and rs1060822, were significantly associated with NAFLD, even when the most conservative Bonferroni's correction was applied. Linkage disequilibrium analysis revealed that SNP rs1060822 and three other SNP, rs2297510, rs2297511 and rs2797512, were in the same block. We also investigated associations between rs1060822 genotypes and the fibrosis index, and the results of the analysis revealed an additive increase in the fibrosis index and intrahepatic iNOS mRNA expression in the patients with the T allele of rs1060822. Conclusion: This is the first study to identify genetic variations in iNOS that may influence the risk of NAFLD and liver fibrosis in NAFLD.
Notes:
Koji Fujita, Yuichi Nozaki, Koichiro Wada, Masato Yoneda, Yoko Fujimoto, Mihoyo Fujitake, Hiroki Endo, Hirokazu Takahashi, Masahiko Inamori, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima (2009)  Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis.   Hepatology 50: 3. 772-780 Sep  
Abstract: The specific mechanisms of nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) pathogenesis remain unknown. In the present study we investigated the differences between NAFL and NASH in terms of liver lipid metabolites and serum lipoprotein. In all, 104 Japanese subjects (50 men and 54 postmenopausal women) with histologically verified NAFL disease (NAFLD) (51 with NAFL, 53 with NASH) were evaluated; all diagnoses were based on liver biopsy findings and the proposed diagnostic criteria. To investigate the differences between NAFL and NASH in humans, we carefully examined (1) lipid inflow in the liver, (2) lipid outflow from the liver, (3) very-low-density lipoprotein (VLDL) synthesis in the liver, (4) triglyceride (TG) metabolites in the liver, and (5) lipid changes and oxidative DNA damage. Most of the hepatic lipid metabolite profiles were similar in the NAFL and NASH groups. However, VLDL synthesis and lipid outflow from the liver were impaired, and surplus TGs might have been produced as a result of lipid oxidation and oxidative DNA damage in the NASH group. Conclusion: A growing body of literature suggests that a deterioration in fatty acid oxidation and VLDL secretion from the liver, caused by the impediment of VLDL synthesis, might induce serious lipid oxidation and DNA oxidative damage, impacting the degree of liver injury and thereby contributing to the progression of NASH. Therefore, dysfunctional VLDL synthesis and release may be a key factor in progression to NASH.
Notes:
Keiko Akimoto, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Tomoyuki Akiyama, Tamon Ikeda, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima (2009)  Does postprandial coffee intake enhance gastric emptying?: a crossover study using continuous real time 13C breath test (BreathID system).   Hepatogastroenterology 56: 91-92. 918-920 May/Jun  
Abstract: Coffee is one of the most popular beverages worldwide, however, few studies have examined the effects of coffee on the gastrointestinal system. The aim of this study was to determine whether there was a correlation between coffee intake and gastric emptying using a novel non-invasive technique for measuring gastric emptying with a continuous real time 13C breath test (BreathID system: Oridion, Israel).
Notes:
Tomoyuki Akiyama, Masato Yoneda, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Kyoko Yoneda, Koji Fujita, Tomoko Koide, Chikako Tokoro, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima (2009)  Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease.   BMC Gastroenterol 9: 07  
Abstract: The association between obesity and the risk of Barrett's esophagus (BE) is unclear. Furthermore, the association between visceral obesity and the risk of BE is entirely unknown.
Notes:
H Endo, K Hosono, T Fujisawa, H Takahashi, M Sugiyama, K Yoneda, Y Nozaki, K Fujita, M Yoneda, M Inamori, K Wada, H Nakagama, A Nakajima (2009)  Involvement of JNK pathway in the promotion of the early stage of colorectal carcinogenesis under high-fat dietary conditions.   Gut 58: 12. 1637-1643 Dec  
Abstract: The molecular mechanisms underlying the promotion of colorectal carcinogenesis by a high-fat diet (HFD) remain unclear. We investigated the role of the insulin-signal pathway and the c-Jun N-terminal kinase (JNK) pathway, which reportedly play crucial roles in insulin resistance, during colorectal carcinogenesis in the presence of hyperinsulinaemia induced by a HFD.
Notes:
Hiroyuki Kirikoshi, Satoru Saito, Masato Yoneda, Koji Fujita, Hironori Mawatari, Takashi Uchiyama, Takuma Higurashi, Ayumu Goto, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Takashi Sakaguchi, Norio Ueno, Atsushi Nakajima (2009)  Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma.   Hepatol Res 39: 6. 553-562 Jun  
Abstract: Aim: Hepatocellular carcinoma (HCC) is one of the most commonly occurring malignances worldwide. Curative therapies such as resection, percutaneous ethanol injection (PEI) and radiofrequency ablation (RFA) have been applied to patients with early-stage HCC. Patients with more advanced cancers require local or systemic therapies. We present the results of our retrospective review conducted to evaluate whether transarterial chemoembolization (TACE) alone and combined TACE with percutaneous ablation for HCC exhibited superior efficacy to palliative treatment. Methods: The effects of TACE and of the combined therapies (TACE + PEI or TACE + RFA) on the long-term survival rates were evaluated in 268 untreated HCC patients by various statistical analyses. Results: The cumulative survival rates in the TACE alone group were significantly superior to those in the palliative treatment group. Further, the cumulative survival rates in the combined TACE + PEI/RFA group were significantly superior to those in the TACE alone group. When the comparison among the groups was restricted to patients with two or three tumors fulfilling the Milan criteria, significantly greater prolongation of survival was observed in the combined TACE + PEI/RFA group than in the PEI/RFA alone group. Conclusions: The aforementioned treatment modalities yielded greater improvements of the survival rate and survival duration as compared to palliative treatment in HCC patients. Furthermore, in terms of the effect on the survival period, combined TACE + PEI/RFA therapy was more effective than TACE monotherapy, and also more effective than PEI or RFA monotherapy in cases with multiple tumors fulfilling the Milan criteria.
Notes:
Yuichi Nozaki, Koji Fujita, Masato Yoneda, Koichiro Wada, Yoshiyasu Shinohara, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Kensuke Kubota, Satoru Saito, Tetsuya Mizoue, Naohiko Masaki, Yoji Nagashima, Yasuo Terauchi, Atsushi Nakajima (2009)  Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease.   J Hepatol 51: 3. 548-556 Sep  
Abstract: Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome that is closely associated with multiple factors such as obesity, hyperlipidemia, type 2 diabetes mellitus and hypertension, making it difficult to treat NAFLD effectively using any monotherapy available to date. In this study, we propose a novel combination therapy for NAFLD comprising ezetimibe (EZ), a cholesterol absorption inhibitor, and acarbose (AC), an alpha-glucosidase inhibitor.
Notes:
Hiroshi Iida, Masahiko Inamori, Keiko Akimoto, Hironori Mawatari, Hiroki Endo, Yuichi Nozaki, Tomoyuki Akiyama, Tamon Ikeda, Yasunari Sakamoto, Koji Fujita, Kyoko Yoneda, Hirokazu Takahashi, Masato Yoneda, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima (2009)  Early effects of intravenous administrations of lansoprazole and famotidine on intragastric pH.   Hepatogastroenterology 56: 90. 551-554 Mar/Apr  
Abstract: The ideal medication for treatment of acid related diseases should have a rapid onset of action to promote hemostasis. The aim of our study was to investigate the inhibitory effects on gastric acid secretion after single intravenous administrations of lansoprazole 30 mg and famotidine 20 mg.
Notes:
Hiroshi Iida, Masahiko Inamori, Yuichi Nozaki, Hiroki Endo, Kunihiro Hosono, Tomoyuki Akiyama, Yasunari Sakamoto, Hirokazu Takahashi, Tomoko Koide, Chikako Tokoro, Yasunobu Abe, Atsushi Nakajima (2009)  Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values.   BMC Gastroenterol 9: 07  
Abstract: The ideal medication for treatment of acid related diseases should have a rapid onset of action to promote hemostasis and resolution of symptoms. The aim of our study was to investigate the inhibitory effects on gastric acid secretion after a single oral administrations of lafutidine, is a newly synthesized H2-receptor antagonist, with mosapride 5 mg or lafutidine alone.
Notes:
2008
T Fujisawa, H Endo, A Tomimoto, M Sugiyama, H Takahashi, S Saito, M Inamori, N Nakajima, M Watanabe, N Kubota, T Yamauchi, T Kadowaki, K Wada, H Nakagama, A Nakajima (2008)  Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition.   Gut 57: 11. 1531-1538 Nov  
Abstract: The effect of adiponectin on colorectal carcinogenesis has been proposed but not fully investigated. We investigated the effect of adiponectin deficiency on the development of colorectal cancer.
Notes:
Kyoko Yoneda, Ayako Tomimoto, Hiroki Endo, Hiroshi Iida, Michiko Sugiyama, Hirokazu Takahashi, Hironori Mawatari, Yuichi Nozaki, Koji Fujita, Masato Yoneda, Masahiko Inamori, Noriko Nakajima, Koichiro Wada, Yoji Nagashima, Hitoshi Nakagama, Hitoshi Uozaki, Masashi Fukayama, Atsushi Nakajima (2008)  Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue.   Oncol Rep 20: 3. 479-483 Sep  
Abstract: Adiponectin is secreted by adipocytes and is a key hormone responsible for insulin sensitization. Recent studies have shown that plasma adiponectin is decreased in patients with breast, endometrial and gastric cancer. However, the effect of adiponectin on colorectal carcinogenesis is controversial. It is now well known that the adiponectin receptor exists in two isoforms, adiponectin receptor 1 (AdipoR1) and adiponectin receptor 2 (AdipoR2). We examined the expression of the adiponectin receptors on normal colon mucosa and colon cancer tissues in a human study using real-time RT-PCR, Western blotting and immunohistochemical staining. Adiponectin receptors, AdipoR1/AdipoR2, were expressed in normal colon epithelial and colon cancer cells. Furthermore, laser microdissection was performed to confirm our results. These results suggest that adiponectin may exert some effects on normal colon epithelium or colon cancer cells directly through adiponectin receptors. Further studies are required to elucidate the function of the AdipoRs activated by adiponectin and the downstream mechanisms of AdipoRs in colon cancer cells.
Notes:
Y Hattori, S Kobayashi, H Takahashi, M Yoneda, M Inamori, Y Abe, K Kubota, S Saito, A Nakajima (2008)  Gastric inflammatory fibroid polyp treated by endoscopic submucosal dissection.   Case Rep Gastroenterol 2: 2. 283-286 08  
Abstract: The endoscopic examination of a 64-year-old male patient revealed a gastric submucosal tumor in the anterior wall of the gastric antrum. The lesion increased in diameter to 25 mm and was resected completely with endoscopic submucosal dissection (ESD). Histological examination of the submucosal tumor gave a diagnosis of an inflammatory fibroid polyp (IFP). It is suggested that ESD may be an effective and safe therapy for gastric submucosal tumors.
Notes:
Y Hattori, T Higurashi, H Takahashi, M Inamori, Y Abe, Y Rino, A Nakajima (2008)  Gastric varices with remarkable collateral veins in valpronic Acid-induced chronic pancreatitis.   Case Rep Gastroenterol 2: 2. 279-282 08  
Abstract: Valproic acid (VPA) is a commonly prescribed and approved treatment for epilepsy, including Angelman syndrome, throughout the world. However, the long-term administration of drugs like VPA is associated with the possible development of gastric varices and splenic obstruction as a result of chronic pancreatitis. Such cases can be difficult to treat using endoscopy or interventional radiology because of hemodynamic abnormalities; therefore, surgical treatment is often necessary.
Notes:
Masato Yoneda, Kikuko Hotta, Yuichi Nozaki, Hiroki Endo, Takashi Uchiyama, Hironori Mawatari, Hiroshi Iida, Shingo Kato, Kunihiro Hosono, Koji Fujita, Kyoko Yoneda, Hirokazu Takahashi, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Masahiko Inamori, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Shiro Maeyama, Koichiro Wada, Atsushi Nakajima (2008)  Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).   BMC Gastroenterol 8: 06  
Abstract: Genetic factors as well as environmental factors are important in the development of NAFLD and in this study we investigated associations between polymorphisms of peroxisome proliferators-activated receptor gamma coactivator 1alpha polymorphism (PPARGC1A) and NAFLD.
Notes:
Masato Yoneda, Hiroki Endo, Hironori Mawatari, Yuichi Nozaki, Koji Fujita, Tomoyuki Akiyama, Takuma Higurashi, Takashi Uchiyama, Kyoko Yoneda, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Noritoshi Kobayashi, Naotaka Yamaguchi, Shiro Maeyama, Shogo Yamamoto, Shuichi Tsutsumi, Hiroyuki Aburatani, Koichiro Wada, Kikuko Hotta, Atsushi Nakajima (2008)  Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis.   Hepatol Res 38: 12. 1204-1212 Dec  
Abstract: Aim: Non-alcoholic steatohepatitis (NASH) is a subset of non-alcoholic fatty liver disease (NAFLD) and sometimes progresses to cirrhosis and liver failure. In this study we analyzed the expression profile of genes and biological pathways involved in NASH in comparison with non-NASH by gene set enrichment analysis (GSEA) employing a DNA microarray technique. Methods: mRNA from liver biopsy specimens was collected from a group of NASH patients and a group of non-NASH patients. We analyzed the relative abundance of mRNA using high-density oligonucleotide microarrays containing probes for 54 675 known genes, and investigated the pathogenetic mechanisms of NASH by means of a powerful technique for analyzing molecular profiling data, GSEA. Results: The results showed that the level of expression of 27 gene sets was significantly higher and the level of expression of 25 gene sets was significantly lower in the NASH samples than in the non-NASH samples. Based on these results we created an online, publicly available, searchable database containing the data for the gene expression profiles of the NASH patients (http://www2.genome.rcast.u-tokyo.ac.jp/___/NASH/NASH_GSEA2/). Conclusion: Our data revealed differences in expression of many gene sets that are involved in the pathogenesis of NASH.
Notes:
K Fujita, Y Nozaki, K Wada, M Yoneda, H Endo, H Takahashi, T Iwasaki, M Inamori, Y Abe, N Kobayashi, H Kirikoshi, K Kubota, S Saito, Y Nagashima, A Nakajima (2008)  Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease.   Gut 57: 11. 1583-1591 Nov  
Abstract: No effective drugs have been developed to date to prevent or treat non-alcoholic fatty liver disease (NAFLD), although diet modification and exercise to improve obesity have been attempted. Therefore, development of a novel drug/strategy to treat NAFLD is urgently needed. In the present study, a novel concept is proposed for the treatment of NAFLD.
Notes:
Y Kitai, H Takahashi, A Goto, H Iida, H Mawatari, K Fujita, M Yoneda, M Inamori, Y Abe, N Kobayashi, H Kirikoshi, K Kubota, S Saito, A Nakajima (2008)  Chemotherapeutic treatment of priapism in metastatic rectal cancer.   Case Rep Gastroenterol 2: 3. 505-508 Sep  
Abstract: A 65-year-old man was admitted with penile tenderness and dysuria due to priapism. Enhanced computed tomography revealed metastatic tumors in the liver, lung, sacrum and lymph nodes. Advanced rectal cancer, detected by colonoscopy as a primary tumor, was treated with chemotherapy (FOLFOX4). Although the rectal cancer showed no change, five months of chemotherapy improveid the priapism, suggesting that chemotherapy can improve rare symptoms of rectal cancer.
Notes:
Hironori Mawatari, Hiroyuki Kirikoshi, Masato Yoneda, Takuma Higurashi, Koji Fujita, Satoru Saito, Masahiko Inamori, Hirokazu Takahashi, Yasunobu Abe, Kensuke Kubota, Atsushi Nakajima (2008)  Effective treatment for advanced hepatocellular carcinoma with portal venous invasion using a combination therapy of intra-arterial 5-fluorouracil and subcutaneous pegylated-interferon-alpha-2b.   Hepatogastroenterology 55: 86-87. 1776-1777 Sep/Oct  
Abstract: Hepatocellular carcinoma with portal venous invasion has a poor prognosis. We report a case treated successfully by intra-arterial 5-fluorouracil with systemic pegylated-interferon-alpha-2b instead of conventional interferon-alpha. A 66-year-old man was admitted to our hospital, and diagnosed with hepatocellular carcinoma with portal venous invasion. Following informed consent, he was treated with eight week cycles of combination chemotherapy using intra-arterial 5-fluorouracil (500 mg/body/day i.a., days 1-5, 8-12 continuously) and pegylated-interferon-alpha-2b (100 microg body s.c., days 1, 8). No significant side effects were observed during his therapy. After 4 cycles, computed tomography scan revealed a partial response of tumor reduction. This is the first report of advanced hepatocellular carcinoma effectively treated using subcutaneous pegylated-interferon-alpha-2b with intra-arterial 5-fluorouracil. While the conventional therapy of interferon-alpha with 5-fluorouracil has significant side effects, no significant side effects were observed in our case. The use of subcutaneous pegylated-interferon-alpha-2b combined with intraarterial 5-fluorouracil, may improve patients' quality of life.
Notes:
Hiroki Endo, Yasuyuki Kondo, Masahiko Inamori, Tomohiko R Ohya, Tatsuro Yanagawa, Masako Asayama, Kantaro Hisatomi, Takuma Teratani, Masato Yoneda, Atsushi Nakajima, Nobuyuki Matsuhashi (2008)  Ingesting 500 ml of polyethylene glycol solution during capsule endoscopy improves the image quality and completion rate to the cecum.   Dig Dis Sci 53: 12. 3201-3205 Dec  
Abstract: The benefits of bowel preparation prior to capsule endoscopy (CE) are controversial. The aim of this study was to examine whether ingesting a small amount of polyethylene glycol (PEG) during, not before, the CE procedure improves the image quality and the cecal completion rate. A prospective single-blind controlled study was conducted including 59 patients. The initial 32 patients (group A) received no preparation, and the subsequent 27 patients (group B) ingested 500 ml of PEG starting 30 min after swallowing the capsule. The capsule reached the cecum in 65.6% of the patients in group A and 88.9% of the patients in group B (P = 0.038). The use of PEG during CE examination significantly improved the image quality, and this effect was more pronounced in the distal ileum. Ingesting a small amount of PEG during CE examination significantly improves both the CE image quality and the cecal completion rate.
Notes:
Atsushi Nakajima, Hirokazu Takahashi, Masahiko Inamori, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Shoji Yamanaka (2008)  Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case report.   J Med Case Reports 2: 12  
Abstract: The granulocyte-colony stimulating factor-producing tumor was first reported in 1977, however, anaplastic pleomorphic type carcinoma of the pancreas producing granulocyte-colony stimulating factor is still rare.
Notes:
Tomoyuki Akiyama, Masahiko Inamori, Hiroshi Iida, Hironori Mawatari, Hiroki Endo, Kunihiro Hosono, Kyoko Yoneda, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Atsushi Nakajima (2008)  Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men.   BMC Gastroenterol 8: 12  
Abstract: Evidence regarding the association between alcohol consumption and the gastro-esophageal reflux disease (GERD) spectrum has been conflicting. We examined the association between alcohol consumption and erosive esophagitis and Barrett's epithelium in Japanese men.
Notes:
Masato Yoneda, Takashi Uchiyama, Shingo Kato, Hiroki Endo, Koji Fujita, Kyoko Yoneda, Hironori Mawatari, Hiroshi Iida, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Shiro Maeyama, Mina Sagara, Hiroyuki Aburatani, Tatsuhiko Kodama, Atsushi Nakajima (2008)  Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH).   BMC Gastroenterol 8: 11  
Abstract: The changes in the liver in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However it has remained difficult to differentiate between NASH and non-progressive NAFLD on the basis of the clinical findings alone.
Notes:
Noritoshi Kobayashi, Takuma Higurashi, Hiroshi Iida, Hironori Mawatari, Hiroki Endo, Yuichi Nozaki, Ayako Tomimoto, Kyoko Yoneda, Tomoyuki Akiyama, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima, Shoji Yamanaka, Yoshiaki Inayama (2008)  Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM).   J Hepatobiliary Pancreat Surg 15: 5. 531-535 10  
Abstract: We report a rare case of adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM) in which parathyroid hormone-related protein (PTH-rP) was identified as the causative factor of hypercalcemia. A 72-year-old Japanese man was admitted to our institution complaining of fever and abdominal pain. Abdominal computed tomography demonstrated a large tumor in the body of the pancreas, with multiple liver metastases. Both serum calcium and PTH-rP levels were elevated. No accumulation was observed on bone scan with technetium-99. The patient died of pneumonia 3 months after admission. Autopsy demonstrated that the neoplasm in the pancreas showed an abrupt histological transition from adenocarcinoma to squamous cell carcinoma. PTH-rP was identified in the primary pancreatic tumor cells by immunohistochemical examination and a reverse-transcription polymerase chain reaction (RTPCR) method. We concluded that PTH-rP was the causative factor of the HHM, based on the laboratory data, immunohistochemical examination, and messenger RNA (mRNA) expression. This is a very rare report of adenosquamous cell carcinoma of the pancreas associated with HHM.
Notes:
Atsushi Nakajima, Ayako Tomimoto, Koji Fujita, Michiko Sugiyama, Hirokazu Takahashi, Ikuko Ikeda, Kunihiro Hosono, Hiroki Endo, Kyoko Yoneda, Hiroshi Iida, Masahiko Inamori, Kensuke Kubota, Satoru Saito, Noriko Nakajima, Koichiro Wada, Yoji Nagashima, Hitoshi Nakagama (2008)  Inhibition of peroxisome proliferator-activated receptor gamma activity suppresses pancreatic cancer cell motility.   Cancer Sci 99: 10. 1892-1900 Oct  
Abstract: Peroxisome proliferator-activated receptor gamma (PPARgamma) is a ligand-activated transcription factor that has been implicated in the carcinogenesis and progression of various solid tumors, including pancreatic carcinomas. We aimed to clarify the role of this receptor in pancreatic cell motility in vitro and in metastasis in vivo. Cell motility was examined by assaying transwell migration and wound filling in Capan-1 and Panc-1 pancreatic cancer cells, with or without the PPARgamma-specific inhibitor T0070907. A severe combined immunodeficiency xenograft metastasis model was used to examine the in vivo effect of PPARgamma inhibition on pancreatic cancer metastasis. In both transwell-migration and wound-filling assays, inhibition of PPARgamma activity suppressed pancreatic cell motility without affecting in vitro cell proliferation. Inhibition of PPARgamma also suppressed liver metastasis in vivo in metastatic mice. In PPARgamma-inhibited cells, p120 catenin accumulation was induced predominantly in cell membranes, and the Ras-homologous GTPases Rac1 and Cdc42 were inactive. Inhibition of PPARgamma in pancreatic cancer cells decreased cell motility by altering p120ctn localization and by suppressing the activity of the Ras-homologous GTPases Rac1 and Cdc42. Based on these findings, PPARgamma could function as a novel target for the therapeutic control of cancer cell invasion or metastasis.
Notes:
Kensuke Kubota, Shingo Kato, Tomoyuki Akiyama, Masato Yoneda, Koji Fujita, Masami Ogawa, Masahiko Inamori, Noritoshi Kobayashi, Satoru Saito, Yukio Kakuta, Hisashi Ohshiro, Atsushi Nakajima (2008)  Differentiating sclerosing cholangitis caused by autoimmune pancreatitis and primary sclerosing cholangitis according to endoscopic duodenal papillary features.   Gastrointest Endosc 68: 6. 1204-1208 Dec  
Abstract: Differentiating primary sclerosing cholangitis (PSC) and sclerosing cholangitis caused by autoimmune pancreatitis (SC-AIP) is often challenging. Recently, endoscopic findings of the duodenal papilla in cases with AIP or PSC were reported by Unno and Parlak, although the endoscopic differentiation of these 2 conditions has not yet been fully clarified.
Notes:
Toshio Fujisawa, Michiko Sugiyama, Ayako Tomimoto, Koichiro Wada, Hiroki Endo, Hirokazu Takahashi, Kyoko Yoneda, Masato Yoneda, Masahiko Inamori, Satoru Saito, Yasuo Terauchi, Takashi Kadowaki, Naoto Tsuchiya, Hitoshi Nakagama, Atsushi Nakajima (2008)  Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin / T cell factor (TCF) pathway in the mouse intestine.   J Pharmacol Sci 108: 4. 535-544 Dec  
Abstract: Although peroxisome proliferator-activated receptor gamma (PPARgamma) is strongly expressed in the intestinal epithelium, the role of PPARgamma in intestinal tumorigenesis has not yet been elucidated. To address this issue, we investigated the effect of PPARgamma inhibition and its mechanism on intestinal tumorigenesis using a selective antagonist, T0070907. We treated Apc(Min/+) mice and carcinogen-induced colon cancer model C57BL/6 mice with T0070907 and counted the number of spontaneous polyps and aberrant crypt foci and observed cell proliferation and beta-catenin protein in the colon epithelium. To investigate its mechanism, the changes of beta-catenin/TCF (T cell factor) transcriptional activity and location of beta-catenin induced by T0070907 were investigated in the colon cancer cell lines. T0070907 promoted polyp formation in the small intestine of Apc(Min/+) mice and aberrant crypt foci in the colon of C57BL/6 mice. PPARgamma inhibition promoted cell proliferation and increased expressions of the c-myc and cyclin D1 genes and the beta-catenin protein in the colon epithelium. In vitro, cell proliferation was promoted, but it was inhibited by the transfection of dominant-negative Tcf4. T0070907 increased beta-catenin/TCF transcriptional activity and beta-catenin protein in the cytsol and nucleus, but relatively decreased it on the cell membrane. PPARgamma antagonist promotes tumorigenesis in the small intestine and colon through stimulation of epithelial cell proliferation. beta-Catenin contributes to the promotion of tumorigenesis by PPARgamma antagonist due to activation of TCF/LEF (lymphoid enhancer factor) transcriptional factor.
Notes:
Kensuke Kubota, Yukio Kakuta, Yoshiaki Inayama, Masato Yoneda, Yasunobu Abe, Masahiko Inamori, Hiroyuki Kirikoshi, Satoru Saito, Atsushi Nakajima, Kazuya Sugimori, Kenichi Matuo, Takeda Kazunaga, Hiroshi Shimada (2008)  Clinicopathologic study of resected cases of primary carcinoma of the cystic duct.   Hepatogastroenterology 55: 85. 1174-1178 Jul/Aug  
Abstract: There have been few reports of primary carcinoma of the cystic duct (CCD) included in advanced cases. The aim of this study was to elucidate the clinical features of resected CCD.
Notes:
Tomoyuki Akiyama, Masahiko Inamori, Satoru Saito, Hirokazu Takahashi, Masato Yoneda, Koji Fujita, Toshio Fujisawa, Yasunobu Abe, Hiroyuki Kirikoshi, Kensuke Kubota, Michio Ueda, Kuniya Tanaka, Shinji Togo, Norio Ueno, Hiroshi Shimada, Atsushi Nakajima (2008)  Levovist ultrasonography imaging in intracystic hemorrhage of simple liver cyst.   World J Gastroenterol 14: 5. 805-807 Feb  
Abstract: The differential diagnosis between intracystic hemorrhage and cystadenocarcinoma of the liver is often difficult even with the use of various imaging modalities. A 73-year-old woman was admitted to our hospital with the complaint of right upper quadrant pain. Ultrasonography (US) demonstrated a heterogeneous echogenic cyst measuring 11 cm multiply 8 cm in size in S2 of the liver, indicated intracystic hemorrhage of simple liver cyst or cystadenocarcinoma, but the differential diagnosis was considerably difficult. Levovist (Schering, Berlin, Germany) US revealed no enhancement of the intracystic structures, suggesting a clot in the case of intracystic hemorrhage. An operation was performed and the resected lesion showed a solitary benign liver cyst, measuring 5.5 cm multiply 4.7 cm multiply 8.5 cm containing a large blood clot. The patient had an uneventful recovery after the surgery. Levovist US may play an important role in discrimination between intracystic hemorrhage of simple hepatic cysts and cystadenocarcinoma of the liver.
Notes:
M Yoneda, H Mawatari, K Fujita, H Endo, H Iida, Y Nozaki, K Yonemitsu, T Higurashi, H Takahashi, N Kobayashi, H Kirikoshi, Y Abe, M Inamori, K Kubota, S Saito, M Tamano, H Hiraishi, S Maeyama, N Yamaguchi, S Togo, A Nakajima (2008)  Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).   Dig Liver Dis 40: 5. 371-378 May  
Abstract: Liver fibrosis is the main predictor of the progression of nonalcoholic fatty liver disease. Transient elastography (FibroScan), which measures liver stiffness, is a novel, noninvasive method to assess liver fibrosis.
Notes:
Noritoshi Kobayashi, Masahiko Inamori, Koji Fujita, Toshio Fujisawa, Nobutaka Fujisawa, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Harunobu Kawamura, Takeshi Shimamura, Hiroyuki Kirikoshi, Kensuke Kubota, Takashi Sakaguchi, Satoru Saito, Lawrence J Saubermann, Atsushi Nakajima (2008)  Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms.   J Hepatobiliary Pancreat Surg 15: 2. 169-177 04  
Abstract: Intraductal papillary-mucinous neoplasms (IPMNs) of the pancreas have a favorable prognosis. However, invasive ductal carcinomas of the pancreas show a rapid progression. The aim of this study was to investigate gene mutations in pure pancreatic juice from IPMN patients and to define these genetic mutations in relation to the histopathological and clinical features of IPMNs.
Notes:
Noritoshi Kobayashi, Koji Fujita, Toshio Fujisawa, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Masahiko Inamori, Hiroyuki Kirikoshi, Kennsuke Kubota, Satoru Saito, Atsushi Nakajima (2008)  [Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?].   Gan To Kagaku Ryoho 35: 1. 65-70 Jan  
Abstract: The objective of this study was to clarify the clinical features of long-time survivors with unresectable pancreatic cancer treated by gemcitabine(GEM)alone and to predict survival time by carbohydrate antigen(CA)19-9, enhanced computed tomography(CT), and 18F-fluoro-2-deoxy-D-glucose positron emission tomography(FDG-PET) in monitoring the response to chemotherapy. Twenty-one patients with unresectable pancreatic cancer were enrolled in this study. All patients were evaluated by serum CA19-9 level, tumor size of CT, maximum standardized uptake value (SUVmax)with FDG-PET and other factors before chemotherapy(GEM alone at a dose of 1,000 mg/m(2) weekly x 3 followed by 1 week of rest), and they received chemotherapy until obviously progressive disease. Serum CA19-9, tumor size of CT and SUVmax with PET were measured after three courses of chemotherapy in ten patients. We compared these three modalities in terms of two points: Which is the best modality to predict survival time ? Which is the best monitoring modality to evaluate the efficacy of chemotherapy on unresectable pancreatic cancer ? A significant difference in survival time was not found between high level group and low level group of serum CA19-9 level and SUVmax with FDG-PET and also longest length of tumor by enhanced CT. In ten patients we evaluated the response rate of each parameter CA19-9(IU/mL), CT(longest length of tumor), and SUVmax with FDG-PET. We defined the response rate(pretreatment level of CA19-9 or longest length of tumor or SUVmax-after 3 courses chemotherapy level of CA19-9 or longest length of tumor or SUVmax/pretreatment level of CA19-9 or longest length of tumor or SUVmax). Response rate of CA19-9 was significantly correlated with survival time(r=0.633, p=0.0481). However, the response rate of SUVmax with FDG-PET had no significant correlation with survival time(r=0.019, p=0.9630). In the present study, the response rate of CA19-9 is the best monitoring modality to evaluate the efficacy of chemotherapy.
Notes:
Hiroki Endo, Nobuyuki Matsuhashi, Masahiko Inamori, Keiko Akimoto, Tomohiko Ohya, Tatsuro Yanagawa, Masako Asayama, Kantaro Hisatomi, Takuma Teratani, Koji Fujita, Masato Yoneda, Atsushi Nakajima (2008)  Rebleeding rate after interventional therapy directed by capsule endoscopy in patients with obscure gastrointestinal bleeding.   BMC Gastroenterol 8: 04  
Abstract: The precise role of capsule endoscopy in the diagnostic algorithm of obscure gastrointestinal bleeding has yet to be determined. Despite the higher diagnostic yield of capsule endoscopy, the actual impact on clinical outcome remains poorly defined. The aim of this study was to evaluate the follow-up results of patients with obscure gastrointestinal bleeding to determine which management strategies after capsule endoscopy reduced rebleeding.
Notes:
2007
Masato Yoneda, Hironori Mawatari, Koji Fujita, Kyoko Yonemitsu, Shingo Kato, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Shinji Togo, Shiro Maeyama, Atsushi Nakajima (2007)  Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage.   J Gastroenterol 42: 5. 375-381 May  
Abstract: The changes in nonalcoholic fatty liver disease range over a wide spectrum, extending from simple steatosis to nonalcoholic steatohepatitis (NASH). We investigated the clinical usefulness of the type IV collagen 7s domain and hyaluronic acid for predicting the severity of fibrosis before progression to the cirrhotic stage in NASH patients.
Notes:
Masato Yoneda, Hironori Mawatari, Koji Fujita, Hiroshi Iida, Kyoko Yonemitsu, Shingo Kato, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Shinji Togo, Shiro Maeyama, Atsushi Nakajima (2007)  High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.   J Gastroenterol 42: 7. 573-582 Jul  
Abstract: The changes in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However, it has remained difficult to differentiate between NASH and nonprogressive NAFLD by clinical examination. We investigated the interrelationships between serum high-sensitivity C-reactive protein (hs-CRP) and the pathogenesis and progression of NASH.
Notes:
Masahiko Inamori, Tomoyuki Akiyama, Keiko Akimoto, Koji Fujita, Hirokazu Takahashi, Masato Yoneda, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Norio Ueno, Atsushi Nakajima (2007)  Early effects of peppermint oil on gastric emptying: a crossover study using a continuous real-time 13C breath test (BreathID system).   J Gastroenterol 42: 7. 539-542 Jul  
Abstract: The aim of this study was to determine whether there was a correlation between peppermint oil and gastric emptying by using a novel noninvasive technique for measuring gastric emptying with a continuous real-time (13)C breath test (BreathID system, Oridion, Israel).
Notes:
Kensuke Kubota, Toshio Fujisawa, Yasunobu Abe, Masahiko Inamori, Hiroyuki Kirikoshi, Satoru Saito, Atushi Nakajima (2007)  Clinical significance of the duodenal papilla in patients with separate orifices for the bile and pancreatic ducts.   J Gastroenterol 42: 1. 70-78 Jan  
Abstract: There have been few reports of separate orifices (SPO) for the bile and pancreatic ducts. The aim of this study was to elucidate the clinical significance of SPO.
Notes:
Masato Yoneda, Tomoyuki Iwasaki, Koji Fujita, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Shiro Maeyama, Koichiro Wada, Satoru Saito, Yasuo Terauchi, Atsushi Nakajima (2007)  Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.   Alcohol Clin Exp Res 31: 1 Suppl. S15-S21 Jan  
Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver injury. The spectrum of NAFLD is broad, extending from simple steatosis through nonalcoholic steatohepatitis (NASH). Insulin resistance has been found to increase the risk of NASH, and obesity, and decreased levels of adiponectin are important factors in determining the severity of insulin resistance. Recent evidence has indicated that hypoadiponectinemia is involved in hepatic steatosis and NASH.
Notes:
Koji Fujita, Masato Yoneda, Koichiro Wada, Hironori Mawatari, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Shiro Maeyama, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Atsushi Nakajima (2007)  Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats.   Dig Dis Sci 52: 12. 3455-3464 Dec  
Abstract: The term nonalcoholic steatohepatitis (NASH) has recently been proposed to identify a fatty liver disease accompanied by diffuse fatty infiltration and inflammation. However, no drug therapy has been established for NASH as yet. In the present study, we demonstrate the effect of the angiotensin II type 1 receptor antagonist telmisartan on the development of NASH in a rat model. Telmisartan, but not the angiotensin receptor antagonist valsartan, markedly attenuated hepatic steatosis, inflammation, and fibrosis in these rats. The quantitative parameters of steatosis, inflammation, and fibrosis were also ameliorated by treatment with telmisartan. Compared with telmisartan, the peroxisome proliferator-activated receptor-gamma agonist pioglitazone attenuated hepatic steatosis and fibrosis of the liver to a similar degree. However, telmisartan, but not pioglitazone, dramatically decreased both subcutaneous and visceral fat. In conclusion, these results indicated that telmisartan should be the drug of first choice for the treatment of patients with NASH.
Notes:
Ikuko Ikeda, Ayako Tomimoto, Koichiro Wada, Toshio Fujisawa, Koji Fujita, Kyoko Yonemitsu, Yuichi Nozaki, Hiroki Endo, Hirokazu Takahashi, Masato Yoneda, Masahiko Inamori, Kensuke Kubota, Satoru Saito, Yoji Nagashima, Hitoshi Nakagama, Atsushi Nakajima (2007)  5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model.   Clin Cancer Res 13: 21. 6527-6531 Nov  
Abstract: The risk of colorectal cancer is increased in patients with inflammatory bowel diseases, especially those with ulcerative colitis (UC). Although 5-aminosalicylic acid (5-ASA) is widely used in the treatment of UC to suppress the colitic inflammation, no studies have been conducted to examine the chemopreventive effect of 5-ASA, given in the remission phase of colitis, against colitis-associated cancer using animal models. We therefore investigated the possible inhibition by peroxisome proliferator-activated receptor-gamma (PPARgamma) ligands and 5-ASA of colitis-associated colon carcinogenesis in a mouse model.
Notes:
Kensuke Kubota, Hiroshi Iida, Toshio Fujisawa, Masami Ogawa, Masahiko Inamori, Satoru Saito, Yukio Kakuta, Hisashi Oshiro, Atsushi Nakajima (2007)  Clinical significance of swollen duodenal papilla in autoimmune pancreatitis.   Pancreas 35: 4. e51-e60 Nov  
Abstract: To evaluate the clinical significance of a swollen main duodenal papilla and the associated immunohistopathologic findings in patients with autoimmune pancreatitis (AIP).
Notes:
Hirokazu Takahashi, Kyoko Yoneda, Ayako Tomimoto, Hiroki Endo, Toshio Fujisawa, Hiroshi Iida, Hironori Mawatari, Yuichi Nozaki, Tamon Ikeda, Tomoyuki Akiyama, Masato Yoneda, Masahiko Inamori, Yasunobu Abe, Satoru Saito, Atsushi Nakajima, Hitoshi Nakagama (2007)  Life style-related diseases of the digestive system: colorectal cancer as a life style-related disease: from carcinogenesis to medical treatment.   J Pharmacol Sci 105: 2. 129-132 Oct  
Abstract: Life style-related diseases are associated with an increased risk of colorectal cancer (CRC). Recently, an association has been demonstrated between obesity and CRC. CRC has been associated with markers of insulin or glucose control, and insulin resistance might be the unifying mechanism by which several risk factors affect colorectal carcinogenesis. We evaluated the association between the number of aberrant crypt foci (ACF) and obesity, insulin resistance, hyperlipidemia, and other factors of life style-related disease. As a result, age, body mass index (BMI), waist circumference, and visceral fat obesity were significantly associated with the number of ACF. These results suggest that visceral fat obesity is an important target for CRC prevention. Peroxisome proliferator-activated receptor gamma (PPARgamma) is a member of the nuclear receptor superfamily and is highly expressed in CRC. PPARgamma ligand administration for 1 to 8 months significantly reduced the number of ACF in human subjects. PPARgamma ligand is a promising candidate as a chemopreventive agent. Further investigation is needed to elucidate these mechanisms.
Notes:
M Yoneda, S Saito, T Ikeda, K Fujita, H Mawatari, H Kirikoshi, M Inamori, Y Nozaki, T Akiyama, H Takahashi, Y Abe, K Kubota, T Iwasaki, Y Terauchi, S Togo, A Nakajima (2007)  Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients.   J Viral Hepat 14: 9. 600-607 Sep  
Abstract: Insulin resistance (IR) is known to be associated with the visceral adipose tissue area. Elucidation of the relationship between hepatitis C virus (HCV) and IR is of great clinical relevance, because IR promotes liver fibrosis. In this study, we tested the hypothesis that HCV infection by itself may promote IR. We prospectively evaluated 47 patients with chronic HCV infection who underwent liver biopsy. Patients with obesity, type 2 diabetes mellitus (DM), or a history of alcohol consumption were excluded. IR was estimated by calculation of the modified homeostasis model of insulin resistance (HOMA-IR) index. Abdominal fat distribution was determined by computed tomography. Fasting blood glucose levels were within normal range in all the patients. The results of univariate analysis revealed a significant correlation between the quantity of HCV-RNA and the HOMA-IR (r = 0.368, P = 0.0291). While a significant correlation between the visceral adipose tissue area and the HOMA-IR was also observed in the 97 control, nondiabetic, non-HCV-infected patients (r = 0.398, P < 0.0001), no such significant correlation between the visceral adipose tissue area and the HOMA-IR (r = 0.124, P = 0.496) was observed in the patients with HCV infection. Multiple regression analysis with adjustment for age, gender and visceral adipose tissue area revealed a significant correlation between the HCV-RNA and the HOMA-IR (P = 0.0446). HCV is directly associated with IR in a dose-dependent manner, independent of the visceral adipose tissue area. This is the first report to demonstrate the direct involvement of HCV and IR in patients with chronic HCV infection.
Notes:
2006
Hideyuki Kayama, Masahiko Inamori, Jun-ichi Togawa, Takeshi Shimamura, Yoko Tokita, Tadashi Umezawa, Takashi Sakaguchi, Makoto Naitoh, Hajime Nagase, Atsushi Nakajima, Toshifumi Saito, Shizuo Tominaga, Norio Ueno, Katsuaki Tanaka, Hisahiko Sekihara (2006)  Pleural effusions following endoscopic injection sclerotherapy for cirrhotic patients with esophageal varices.   Hepatogastroenterology 53: 69. 376-380 May/Jun  
Abstract: Endoscopic injection sclerotherapy is in widespread use for patients with esophageal varices. It is well known that pleural effusions are among complications following endoscopic sclerotherapy. However, there are few studies regarding the proportion of patients developing pleural effusions after sclerotherapy.
Notes:
Masahiko Inamori, Takeshi Shimamura, Hajime Nagase, Yasunobu Abe, Tadashi Umezawa, Atsushi Nakajima, Toshifumi Saito, Norio Ueno, Katsuaki Tanaka, Hisahiko Sekihara, Jun-ichi Togawa, Hiroki Kaifu, Hideo Tsuboi, Hideyuki Kayama, Shizuo Tominaga (2006)  mRNA expression of inducible nitric oxide synthase, endothelial nitric oxide synthase and vascular endothelial growth factor in esophageal mucosa biopsy specimens from patients with reflux esophagitis.   Hepatogastroenterology 53: 69. 361-365 May/Jun  
Abstract: Nitric oxide (NO) production is elevated in the intestine and may contribute to intestinal injury during inflammation. However, how the expression of inducible NO synthase (iNOS) mRNA and endothelial NO synthase (eNOS) mRNA in the esophageal mucosa contribute to mucosal damage caused by reflux esophagitis remains unknown. Since vascular endothelial growth factor (VEGF) exerts its action on microcirculation, contributing to angiogenesis and inflammation, we examined the role of VEGF together with iNOS and eNOS on development of reflux esophagitis.
Notes:
Noritoshi Kobayashi, Koji Fujita, Toshio Fujisawa, Hirokazu Takahashi, Nobutaka Fujisawa, Masato Yoneda, Yasunobu Abe, Masahiko Inamori, Harunobu Kawamura, Hiroyuki Kirikoshi, Takeshi Shimamura, Kensuke Kubota, Takashi Sakaguchi, Satoru Saito, Atsushi Nakajima (2006)  [Clinical features of long time survivors with unresectable pancreatic cancer treated by gemcitabine alone].   Gan To Kagaku Ryoho 33: 2. 207-212 Feb  
Abstract: The objective of this study was to clarify the clinical features of long-time survivors with unresectable pancreatic cancer treated by gemcitabine (GEM) alone and to predict survival time after the first course of treatment. Eighteen consecutive patients (median age 65.3 years, range 49-77 years; 12 males, 6 females) with unresectable pancreatic cancer and a baseline Karnofsky's performance state = or >60 were treated with GEM in a dose of 1,000 mg/m(2) weekly x 3 followed by 1 week of rest until progression. The overall response rate was 0% (CR 0, PR 0, SD 11 cases, and PD 5 cases), and the median survival time (MST) was 268 days. We observed a statistically significant difference in the patients with or without liver metastasis at the start of treatment (131.6 vs 324.9 days; p=0.0045). We also evaluated the usefulness of serial CA 19-9 measurements as a biochemical response marker and an outcome prognostic parameter in patients with unresectable pancreatic cancer receiving GEM alone. We classified two subgroups into responders (patients with a decrease of = or >10% of the baseline CA 19-9 level after 4 weeks of chemotherapy) and non-responder (patients with a increase of the baseline CA 19-9 level or with a decrease of <10% of the baseline CA 19-9 level after 4 weeks of chemotherapy). Responder had a significantly better median survival than non-responders (416.6 vs 138.3 days; p=0.009). In conclusion, CA 19-9 serum concentration serves as an early indicator of response to chemotherapy with GEM alone in unresectable pancreatic cancer.
Notes:
Kensuke Kubota, Yukio Kakuta, Shunji Kawamura, Yasunobu Abe, Masahiko Inamori, Harunobu Kawamura, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Satoru Saito, Atushi Nakajima (2006)  Undifferentiated spindle-cell carcinoma of the gallbladder: an immunohistochemical study.   J Hepatobiliary Pancreat Surg 13: 5. 468-471  
Abstract: A case of undifferentiated spindle-cell carcinoma of the gallbladder is described. A 72-year-old man presented with right hypochondralgia and fever. Imaging studies revealed a well-demarcated solid tumor (with a necrotic center) in the gallbladder that invaded the liver and transverse colon. On gross examination of the surgical specimen, the cut surface of the polypoid tumor showed nodular invasive growth. Microscopically, the tumor was composed of atypical spindle-shaped tumor cells that proliferated in a whirling or interlacing pattern. The tumor also showed foci with a malignant epithelial component that simulated a carcinosarcoma. Immunohistochemically, the biphasic differentiation of the tumor was highlighted by the different immunoreactivity to antibodies against cytokeratins, epithelial membrane antigen (EMA), and vimentin shown by the malignant epithelial components and the spindle-cell components. However the latter showed faint positivity for cytokeratin antibody. These results suggested that the spindle-cell carcinoma of the gallbladder originated from cholecystic mucosa and showed sarcomatous reaction or dedifferentiation, as indicated by the presence of vimentin-positive cells. The proliferation index, as detected by ki-67, in the spindle-cell component was higher than that in the epithelial component, which may account for the more aggressive biological behavior of the spindle-cell component.
Notes:
2005
Jun-ichi Togawa, Masahiko Inamori, Nobutaka Fujisawa, Hirokazu Takahashi, Masato Yoneda, Harunobu Kawamura, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Takashi Sakaguchi, Tomoo Takamura, Atsushi Nakajima, Norio Ueno, Hisahiko Sekihara (2005)  Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy.   Hepatogastroenterology 52: 62. 645-648 Mar/Apr  
Abstract: Triple therapy consisting of lansoprazole, amoxicillin, and clarithromycin (LAC regimen) is widely used to eradicate Helicobacter pylori in Japan. However, the need for appropriate treatment after failure of initial therapy to eradicate H. pylori has been increasing. We therefore assessed the efficacy of a combination of rabeprazole, amoxicillin, and faropenem for second-line eradication therapy.
Notes:
Noriyuki Takahashi, Naoko Tochimoto, Shin-Ya Ohmori, Hiroshi Mamada, Mari Itoh, Masako Inamori, Jun Shinga, Shin-Ichi Osada, Masanori Taira (2005)  Systematic screening for genes specifically expressed in the anterior neuroectoderm during early Xenopus development.   Int J Dev Biol 49: 8. 939-951  
Abstract: A cDNA library derived from the anterior neuroectoderm (ANE) of Xenopus late-gastrula embryos was systematically screened to isolate novel developmental regulatory genes involved in early brain development. We isolated 1,706 5 expressed sequence tags (ESTs), which were subdivided into 1,383 clusters and categorized into 19 classes based on predicted functions according to their similarities to other known genes. Of these, 757 clusters that were considered possible novel regulatory genes or unknown genes were subjected to expression pattern analysis using whole-mount in situ hybridization. Genes from 69 clusters (9%) were expressed in the ANE region. Based on their expression patterns and predicted amino acid sequences, 25 genes were selected for further analysis as novel Xenopus genes expressed broadly or region-specifically in the ANE. Eighteen genes were expressed in postulated patterning centers in the neuroectoderm, including the anterior (four genes) and lateral (nine genes) neural ridges, the midbrain-hindbrain boundary region (one gene) and the midline region of the neural plate (two genes), whereas 13 genes were expressed in the eye anlagen. Therefore, early regionalization of the neuroectoderm appears to occur mainly in those neural patterning centers and the eye anlagen. We determined the entire coding regions of p54nrb, Semaphorin 6D and a novel gene designated scribble-related protein 1 (SCRP1). Interestingly, Semaphorin 6D is expressed in the mesoderm with a dorsoventral gradient, as well as in the ectoderm at the gastrula stage, implying a new role for this protein in development other than in axon guidance.
Notes:
Masahiko Inamori, Jun-Ichi Togawa, Tomoyuki Iwasaki, Yutaka Ozawa, Taisuke Kikuchi, Kenichi Muramatsu, Gaku Chiguchi, Shuhei Matsumoto, Harunobu Kawamura, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Takeshi Shimamura, Kensuke Kubota, Takashi Sakaguchi, Satoru Saito, Norio Ueno, Atsushi Nakajima (2005)  Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?   J Gastroenterol 40: 5. 453-458 May  
Abstract: Medication for the relief of heartburn should have the rapid onset of action required for on-demand use. We studied the inhibition of gastric acid secretion by lafutidine and rabeprazole, given in single doses to fasting and postprandial subjects.
Notes:
Kensuke Kubota, Yasunobu Abe, Masahiko Inamori, Harunobu Kawamura, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Satoru Saito, Norio Ueno, Atushi Nakajima (2005)  Percutaneous transhepatic gallbladder stenting for recurrent acute acalculous cholecystitis after failed endoscopic attempt.   J Hepatobiliary Pancreat Surg 12: 4. 286-289  
Abstract: Endoscopic gallbladder stenting is useful palliative therapy for acute cholecystitis in high-risk patients. Although the success rate of endoscopic gallbladder stenting is 79%-100%, an alternative method has not been reported. We succeeded in employing a method for percutaneous gallbladder stenting (PTGS) and herein describe this new method. A patient with acute acalculous cholecystitis related to ischemic atherosclerotic vascular disease, cholangitis due to Lemmel syndrome, and severe congestive heart failure underwent PTGS through the cystic duct from the gallbladder to the duodenal papilla, because an endoscopic method failed in the treatment of Lemmel syndrome. Because we were unable to place endoscopic transpapillary gallbladder drainage, percutaneous transhepatic gallbladder drainage (PTGBD) was performed and both the cholecystitis and cholangitis ceased. PTGS was performed as an alternative to endoscopic gallbladder stenting. Access to the cystic duct and gallbladder was obtained by the PTGBD route, using a guidewire (0.035-inch diameter) and seeking catheter (6.5 Fr) under fluoroscopic control. A 7-Fr 12-cm double-pigtail biliary polyethylene stent was placed. The patient remained asymptomatic for 3 months after the PTGS until he died, of an acute recurrent myocardial infarction. This new PTGS placement is an alternative treatment for symptomatic gallbladder disease in patients with increased operative risk when the endoscopic method is unsuccessful.
Notes:
2004
Yasunobu Abe, Masahiko Inamori, Jun-Ichi Togawa, Taisuke Kikuchi, Kenichi Muramatsu, Gaku Chiguchi, Harunobu Kawamura, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Takashi Sakaguchi, Tomoo Takamura, Atsushi Nakajima, Norio Ueno, Hisahiko Sekihara (2004)  The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.   J Gastroenterol 39: 1. 21-25 Jan  
Abstract: The ideal medication for the treatment of acid-related diseases, for example, hemorrhagic ulcers and stress-related gastric bleeding, should have a rapid onset of action to promote hemostasis and alleviate symptoms. The aim of our study was to investigate the inhibitory effects on gastric acid secretion after single intravenous administrations of omeprazole 20mg and famotidine 20 mg.
Notes:
2003
Masahiko Inamori, Jun-Ichi Togawa, Hajime Nagase, Yasunobu Abe, Tadashi Umezawa, Atsushi Nakajima, Toshifumi Saito, Norio Ueno, Katsuaki Tanaka, Hisahiko Sekihara, Hiroki Kaifu, Hideo Tsuboi, Hideyuki Kayama, Shizuo Tominaga, Hiroshi Nagura (2003)  Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification.   J Gastroenterol Hepatol 18: 2. 172-176 Feb  
Abstract: Recent studies have shown that the number of patients with reflux esophagitis is increasing in Japan, but the prevalence and risk factors associated with reflux esophagitis in Japanese patients are not well defined.
Notes:
Masahiko Inamori, Jun-ichi Togawa, Kirokazu Takahashi, Masato Yoneda, Nobutaka Fujisawa, Tomoyuki Iwasaki, Yutaka Ozawa, Taisuke Kikuchi, Kenichi Muramatsu, Gaku Chiguchi, Shuhei Matsumoto, Harunobu Kawamura, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Takashi Sakaguchi, Tomoo Takamura, Atsushi Nakajima, Norio Ueno, Hisahiko Sekihara (2003)  Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: which is suitable for on-demand therapy?   J Gastroenterol Hepatol 18: 9. 1034-1038 Sep  
Abstract: An ideal medication for heartburn should have the rapid onset of action needed for on-demand treatment. However, assessment of the onset of action of proton pump inhibitors has been largely subjective. We compared the inhibitory effect on gastric acid secretion of a single oral dose of omeprazole with that of rabeprazole.
Notes:
2002
Jun-Ichi Togawa, Hajime Nagase, Katsuaki Tanaka, Masahiko Inamori, Tadashi Umezawa, Atsushi Nakajima, Makoto Naito, Shinobu Sato, Toshifumi Saito, Hisahiko Sekihara (2002)  Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance.   Am J Physiol Gastrointest Liver Physiol 283: 1. G187-G195 Jul  
Abstract: Natural immunomodulator lactoferrin is known to exert an anti-inflammatory effect. However, there have been no studies that examine the mode of action of lactoferrin in reducing intestinal damage. We investigated the effect of lactoferrin on a trinitrobenzenesulfonic acid (TNBS)-induced colitis model in rats. Bovine lactoferrin was given once daily through gavage, starting 3 days before (preventive mode) or just after TNBS administration (treatment mode) until death. The distal colon was removed to be examined. Colitis was attenuated by lactoferrin via both modes in a dose-dependent manner, as reflected by improvement in macroscopic and histological scores and myeloperoxidase activity. Lactoferrin caused significant induction of the anti-inflammatory cytokines interleukin (IL)-4 and IL-10, significant reductions in the proinflammatory cytokines tumor necrosis factor-alpha and IL-1beta, and downregulation of the nuclear factor-kappaB pathway. We concluded that lactoferrin exerts a protective effect against colitis in rats via modulation of the immune system and correction of cytokine imbalance. Lactoferrin has potential as a new therapeutic agent for inflammatory bowel disease.
Notes:
Jun-Ichi Togawa, Hajime Nagase, Katsuaki Tanaka, Masahiko Inamori, Atsushi Nakajima, Norio Ueno, Toshifumi Saito, Hisahiko Sekihara (2002)  Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance.   J Gastroenterol Hepatol 17: 12. 1291-1298 Dec  
Abstract: The natural immunomodulator, lactoferrin, is widespread among various biological fluids and is known to exert an anti-inflammatory effect. However, there has been only one study that examined the mode of action of lactoferrin in reducing intestinal damage. We investigated the therapeutic role of lactoferrin and its effect on the levels of pro-inflammatory and anti-inflammatory cytokines, by using a rat model of dextran sulfate sodium (DSS) induced-colitis.
Notes:
2001
1997
M Inamori, T Ishigami, N Takahashi, K Hibi, K Ashino, S Sumita, K Tamura, H Ochiai, S Umemura, M Ishii, S Tanaka, H Sekihara, Y Inayama (1997)  [A case of mitochondrial cardiomyopathy with heart failure, sick sinus syndrome and diabetes mellitus: mitochondrial DNA adenine-to-guanine transition at 3243 of mitochondrial tRNA(LEU)(UUR) gene].   J Cardiol 30: 6. 341-347 Dec  
Abstract: A 42-year-old woman with diabetes mellitus lost consciousness and was transferred to the Yokohama City University Hospital. Blood chemistry findings indicated low blood sugar levels and chest X-ray examination revealed cardiomegaly and bilateral pleural effusions. These clinical abnormalities were corrected by treatment with glucose, diuretics, angiotensin converting enzyme inhibitor and digitalis. Cardiological laboratory examinations were performed after admission. Electrocardiography revealed first degree atrioventricular block and incomplete right bundle branch block. Ultrasonography showed lower grade of ejection fraction and diffuse hypokinesis of the cardiac wall. After admission, sinus arrest suddenly occurred. The diagnosis was sick sinus syndrome. Scintigraphy using iodine-123 betamethyl-p-iodophenyl-pentadecanoic acid showed abnormal mottled defects. Coronary angiography found no significant stenosis of the coronary artery. Electron microscopy showed abnormally shaped mitochondrial accumulations in an endomyocardial biopsy specimen. Mitochondrial DNA amplification by polymerase chain reaction followed by restriction enzyme Apa I digestion revealed adenine-to-guanine transition at 3243 of the mitochondrial tRNA(LEU)(UUR) gene.
Notes:
Powered by PublicationsList.org.